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2AB~3TRACT
The nucleotide sequence of a genomic DNA fragment thought
previously to contain the dihydrofolate reductase gene (DFR1)
of Saccharomyces cerevisiae by genetic criteria was
determined. This DNA fragment of 1784' basepairs contains a large
open reading frame from position 800 to 1432, which encodes a
enzyme with a predicted molecular weight of 24,229.8 Daltons.
Analysis of the amino acid sequence of this protein revealed that
the yeast polypep·tide contained 211 amino acids, compared to the
186 residues commonly found in the polypeptides of other
eukaryotes. The difference in size of the gene product can be
attributed mainly to an insert in the yeast gene. Within this
region, several consensus sequences required for processing of
yeast nuclear and class II mitochondrial introns were identified,
but appear not sufficient for the RNA splicing. The primary
structure of the yeast DHFR protein has considerable sequence
homology with analogous polypeptides from other organisms,
especially in the consensus residues involved in cofactor and/or
inhibitor binding. Analysis of the nucleotide sequence also
revealed the presence of a number of canonical sequences
identified in yeast as having some function in the regulation of
gene expression. These include UAS elements (TGACTC) required for
tIle amino acid general control response, and "TATA H boxes as well
as several consensus sequences thought to be required for
transcriptional termination and polyadenylation. Analysis of the
codon usage of the yeast DFRl coding region revealed a codon
bias index of 0.0083. this valve very close to zero suggestes
3that the gene is expressed at a relatively low level under normal
physiological conditions.
The information concerning the organization of the DFRl
were used to construct a variety of fusions of its 5' regulatory
region with the coding region of the lacZ gene of E. coli.
Some of such fused genes encoded a fusion product that expressed
in E.coli and/or in yeast under the control of the 5'
regulatory elements of the DFR1. Further studies with these
fusion constructions revealed that the beta-galactosidase
activity encoded on multicopy plasmids was stimulated transiently
by prior exposure of yeast host cells to UV light. This suggests
that the yeast PFRl gene is indu.ced by UV light and nlay in1ply a
novel function of DHFR protein in the cellular responses to DNA
damage.
Another novel f~ature of yeast DHFR was revealed during
preliminary studies of a diploid strain containing a heterozygous
DFRl null allele. The strain was constructed by insertion of a
URA3 gene within the coding region of DFR1. Sporulation of
this diploid revealed that meiotic products segregated 2:0 for
uracil prototrophy when spore clones were germinated on medium
supplemented with 5-formyltetrahydrofolate (folinic acid). This
finding suggests that, in addition to its catalytic activity, the
DFRl gene product nlay play some role in the anabolisln of
folinic acid. Alternatively, this result may indicate that Ura+
haploid segregants were inviable and suggest that the enzyme has
an essential cellular function in this species.
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INTRODUCTION
Dihydrofolate reductase (DHFR; EC 1.5.1.3) has an essential
role in cellular metabolism and growth. A major function of this
enzyme is to maintain the intracellular pools of reduced folate
cofactors by reducing dihydrofolate (DHF) to tetrahydrofolate
(THF), utilizing nicotinamide adenine dinucleotide phosphate
(NADPH) as coenzyme. Intracellular dihydrofolate may be formed
either through de novo biosynthesis or by the action of
thymidylate synthase (T8). The reduced product (THF), in turn,
serves as a source of metabolically derived THF coenzymes such as
5,10-methylene-THF, 5 or 10-formyl-THF and 5-methyl-THF. Each
\
of these THF cofactors is formed from a particular carbon source
and THF, or derived directly from a metabolic derivative of THF.
These THF coenzymes are required for a number of one-carbon unit
transfer reactions in the biosynthesis of a variety of essential
cellular metabolites including amino acids, purine and the
pyrimidine nucleotide thymidine 5'-monophosphate (see Fig.l;
Blakley, 1969; Chabner, 1982). In addition, a reduced folate is
the donor in the formylation of met-tRNA-FMET required in the
initiation of protein synthesis in prokaryotes and in the
mitochondria of eukaryotes. After reaction of these THF cofactors
with the enzymatic substrate, a new product and unsubstituted THF
are formed. Thus, in most interconversion reactions, THF can be
considered as a carrier of one-carbon units, shuttling back and
forth between the 'loaded' and 'empty' states. In contrast to the
reaction mechanisms of these folate dependent enzymes, in which
the folate cofactor remains at the fully reduced level,
Figure 1 The role of DHFR in cellular metabolism
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thymidylate synthase catalyzes the conversion of deoxyuridylate
(dUMP) to thymidylate (dTMP) by reaction with the methyl donor
5,lO-methylene-THF. Concomitantly, THF is oxidized to DHF. Thus,
the action of DHFR is also required for the regeneration of THF
from the DHF formed in this manner ( Fig.i). This requirement is
essential for all cells, but is especially critical in yeast, as,
in common with most fungi, they lack thymidine kinase activity
and thus possess no salvage pathway for the anabolism of thymine
or thymidine (Grivell and Jackson, 1968). As a consequence, in
yeast, all intracellular dTMP is derived ultimately from dUMPw In
contrast, mammalian cells can synthesize dTMP either by de
novo synthesis from dUMP or from dietary thymidine via the
salvage pathway. As replicating cells have an absolute
requirement for dTMP for DNA synthesis, DHFR must reduce DHF as
rapidly as it is formed by T8 to resupply THF for dTMP synthesis
and to avoid depletion of intracellular THF derivatives required
for other biosynthetic reactions.
Due to this key role in cellular metabolism and growth, DHFR
has long been of significant pharmacological interest as the
target for a number of chemotherapeutic agents. These include
the antineoplastic methotrexate (MTX) , the antibacterial
trimethoprim (Tm) and the antimalarial pyrimethamine, all of
which are potent inhibitors of the enzyme (Roth, 1983; Rollo,
1983; Calabresi and Parks, 1985). Competitive binding of these
inhibitors to DHFR in vivo results in depletion of intra-
cellular THF pools, a consequence of which is a block in de
novo synthesis of purine nucleotides and dTMP, thereby
12
inhibiting DNA synthesis. Ultimately, cells cease dividing and
lose viability (Blakley, 1969). Thus, these drugs have been
employed extensively in chemotherapeutic treatments of neoplastic
disease, bacterial infection and a variety of other clinical
disorders (Bertino and Johns, 1972; Roth and cheng, 1982;
Hitchings, 1983).
Because of the pharmacological importance of the enzyme,
much effort has been directed towards an understanding of the
nature of inhibition of DHFR by various chemicals. Thus, it has
been found that bacterial and eukarotic DHFRs show a wide range
of sensitivity to drugs such as Tm (Burchall, 1974; Baccanari et
al., 1982). In addition, numerous studies have shown that
bacteria often develop resistance to Tm by increased production
of a DHFR isozyme which is not the predominant species in the
parental strain (Hutchison, 1971). Collectively, these
observations have led to an impetus to understand the underlying
molecular basis for the differential effects of drug inhibition
of various DHFR enzymes. It is the hope of investigators taking
this approach that such studies may provide some insight into the
structure of the DHFR protein and its molecular pharmacology in a
variety of cell types and lead to the design of more efficacious
clinical agents with increased selectivity.
The progress of such studies has been facilitated by the
fact that DHFRs are relatively small proteins with molecular
weights ranging from 15,000 to 30,000 Daltons depending on the
source (Blakley, 1969). In addition, resistance to MTX or Tm in
both bacterial and animal cells is often accompanied by a marked
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increase in the production of DHFR. Isolation of drug-resistant
mutants, therefore, has often provided a convenient source of the
large quantities of the protein required for detailed studies of
enzyme mechanics. In addition, the availability of the highly
purified enzyme has made it possible to obtain crystals of the
protein for X-ray crystallographic studies. Thus, the crystal
structure of binary complexes of bacterial and animal DHFRs with
different inhibitors or with the cofactor NADPH (Filman et al.,
1982; Baker et al., 1981 and 1983; Matthews et al., 1977, 1979
and 1985a), and the ternary complexes of bacterial and animal
DHFRs with various inhibitors and NADPH (Mattlews et al., 1978
and 1985b; Bolin et al., 1982; Voltz et al., 1982; Champness et
al., 1986) have been determined. These X-ray crystallographic
studies have suggested tha~. the differential sensitivities of the
animal and bacterial enzymes to Tm and MTX can be accounted for
by slight differences in the portions of the enzyme structure
which interact directly with the inhibitors.
Because of the relative ease with which DHFR protein has
been purified from mutant cells which overproduce DHFR in a
variety of organisms, it is not surprising that during the last
decade or so, the complete primary structure of a number of
bacterial and animal DHFRs has been determined (see Appendix I).
Combined with the X-ray crystallographical data, comparative
studies of the amino acid sequences of DHFRs, from various
sources, have shown that among the amino acid residues involved
in inhibitor and NADPH binding, a small number of them are shared
by both bacterial and animal enzymes (Volz et al., 1982). The
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important role of some of these consensus residues in the
catalytic activity of the enzyme and its inhibition by a variety
of chemical agents has been confirmed by analysis of mutant
enzymes and chemical modification experiments, as well as by
directed mutagenesis studies (Freisheim et al. ,1977; Baccanari et
al. ,1981; Simonsen and Levinson, 1983; Villafranca at al., 1983;
Chen et al., 1985; Howell et al., 1986). Furthermore, bacterial
and animal DHFR complexes with Tm and MTX or substrate have also
been studied extensively by nuclear magnetic resonance (Birdsall
et al. 1977 and 1983; Wyeth et a1., 1980; Cocoo et al., 1981).
Data from these studies have contributed greatly to the
elucidation of the detailed molecular structure of various DHFR
enzymes as well as to an increased understanding of the
mechanics of enzyme catalysis and inhibition. Consequently, DHFR
has rapidly become, without question, the best-understood enzyme
involved in folate intermediary metabolism, in terms of its
physical biochemistry.
In addition to numerous physical and biochemical studies of
the DHFR enzyme, attention to the control of the expression of
the DHFR gene was stimulated by the finding that the use of MTX
and Tm during chemotherapy was often compromised by the emergence
of cells resistant to the inhibitory effects of these drugs.
Research into DHFR gene expression was predicated upon the belief
that studies of the detailed molecular mechanism of drug
resistance might lead to improved strategies for the development
of new therapies that selectively kill resistant cells. In
numerous studies, the development of antifolate drug resistance
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in variety of cell populations was shown to result from anyone
of at least four mechanisms acting separately or in concert.
First, mutations that impaired drug uptake resulted in a
resistant phenotype (Frei et al., 1984). Second, resistance in
bacterial cells was shown to be due to the presence of plasmids
(R-factors) that coded for drug-insensitive DHFRs. It was
concluded that the presence of such a plasmid provided an
alternative nonsusceptible enzyme that permitted bypass of the
metabolic block imposed by the inhibited target DHFR of the host
'bacterium. To date, four distinct types of DHFR encoded by
R-factors have been detected in a variety of clinical isolates
of bacteria.
Type I DHFR was only inhibited by Tm and MTX at levels
several-thousand-fold greater than those which inhibited the
enzyme encoded by the bacterial host. The active form of the
enzyme was a dimer with native molecular weight of 35,000
Daltons, which was approximately twice that of the chromosomally
encoded DHFR (Patlishall at al., 1977; Fling and Elwell, 1980).
The amino acid primary structure deduced from the nucleotide
sequence of the type I DHFR gene, specified by plasmid R 483,
showed that the enzyme was most homologous to wild-type bacterial
DHFRs in the regions thought to be involved in substrate binding,
but showed relatively little homology in the areas lying outside
the active site (Simonsen et al., 1983). Type II DHFR was almost
completely insensitive to the effect of Tm and MTX and was a
tetramer with a native molecular weight of 35,000 Daltons
(Pattishall et al., 1977; Smith et al., 1979). The amino acid
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primary structure (Stone and Smith, 1979) and nucleotide sequence
(Swift et al., 1981) analysis of type II DHFR, specified by the
plasmids R67 and R388, respectively, revealed no homology with
any other known DHFRs from bacterial or animal sources. Both type
I and type II plasmid-encoded DHFRs showed little difference from
the bacterial enzyme in their binding affinities to the substrate
(DHF) or to the cofactor (NADPH) (Pattishall et al., 1977). In
contrast to these plasmid-encoded DHFRs, type I'll enzyme,
specified by plasmid pH21, had a high affinity for DHF and
confered only moderate resistance to Tm upon the host. However,
it showed extreme sensitivity to MTX inhibition (Fling et al.,
1982; Joyner et al., 1984). Recently, a type IV DHFR, encoded by
plasmid pUK1123, has been characterized (Young and Amyes, 1986).
Similar to the type III DHFR, the type IV enzyme confered only a
moderate level of Tm resistance upon its host, but showed a
marked size difference from all other plasmid DHFRs. It had a
relatively high molecula1-' weigl~t of 46,700 Daltons and, its
synthesis was induced in a dose-dependent manner by increasing
concentrations of Tm.
A third mechanism of drug resistance in both bacterial and
animal cells was observed to be due to the expression of a 'novel
DHFR, exhibiting a decreased affinity for the inhibitor, or a
form of DHFR with increased substrate specificity (Flintoff and
Essani, 1980; Goldie et al., 1981; Haber et al., 1981). Analysis
of the mutant DHFRs found in a Tm resistant strain of E. coli
(Baccanari et al., 1981) and in a MTX-resistant line of mouse 3T6
cells (Simonsen and Levinson, 1983) have shown that the altered
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DHFR found in each organism differs from the wild-type enzyme
only at a single amino acid substitution, in the region of the
polypeptide thought to be essential for inhibitor binding.
Recently, an activity-increased form of DHFR was also found in a
MTX-resistant line of human promyelocytic-leukaemia (HL60) cells
(Dedhar et al., 1985).
The final variant exhibiting the drug-resistant phenotype,
observed in these studies, resulted from overproduction of DHFR,
caused either by an increase in the expression of the DHFR gene
at the level of transcription (Sirotnak and McCuen, 1973; Sheldon
and Brenner, 1976) or by gene amplification (Alt et al., 1978).
Studies in bacteria revealed that enzyme overproduction was often
associated with mutations near the structural gene (McCuen and
Sirotnak, 1974; Sheldon, 1977; Smith and Calvo, 1982) which was
shown to result in a corresponding increase in the rate of DHFR
gene transcription ( Sirotnak and McCuen, 1973; Smith and Calvo,
1979)M Analysis of the nucleotide sequence alterations that were
responsible for Tm resistance in these E. Coli mutant strains
indicated that changes had occured in the promoter region of the
DHFR gene which had resulted in an increased homology of this
region to the E. coli promoter consensus sequence. It was
thought that these alterations gave rise to more efficient RNA
polymerase binding at this mutant promoter and thus to an
increase in the level of DHFR gene expression (Smith and Calvo,
1982).
In contrast to the results observed in bacteria, over-
production of DHFR in mammalian cells challenged -with MTX was
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often associated with a corresponding increase in DHFR-specific
mRNA as a consequence of gene amplification, (Alt et al., 1978;
Schimke, 1984). In some cells, the amplified genes were lost upon
continued growth in the absence of MTX, whereas, in other cell
lines, the amplified genes were stable, when the cells were
cultured under non-selective conditions. Subsequently it was
shown that the stably amplified genes were localized to expanded
loci called "homogeneously staining regions" in one 01~ n10re
chromosomes (Nunberg at al., 1978; Masters et al., 1982). In
unstable cells, no change was seen in the chromosomes carrying
the DHFR gene and the amplified DHFR DNA sequences were
associated with large numbers of small extrachromosomal elements
called "double-minute chromosomes" (Kaufman et a1 .. , 1919,; Masters
at al., 1982). Presently, the role of gene amplification in the
development of this mode of MTX resistance and the molecular
mechanism of gene amplification remains unclear. Several models
have been proposed in an attempt to explain these findings,
including unequal sister chromatid exchange or disproportionate
DNA replication, although conclusive evidence for either model is
lacking (Schimke, 1984).
The results of studies, in last a few years, of the physical
structure of the various DHFR genes has greatly facilitated
studies of control of DHFR expression and the mechanism of gene
amplification. Recombinant DNA technology, combined with other
modern molecular approaches, has made it possible to study DHFR
gene regulation in much more detail. Thus, during the past few
years, several bacterial DHFR genes have been cloned and
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sequenced (see Appendix II). In addition, several eukaryotic DHFR
genes have also been isolated on chimeric plasmids. These include
genes encoding enzymes from the mouse (Chang et al., 1978;
Nunberg et al., 1980; Crouse et al., 1982), human (Chen at al.,
1984; Yang et al., 1984) and Chinese hamster cells (Carothers et
al., 1983; Metera et al., 1984) as well as from the baker's yeast
~. cerevisiae (Nath and Baptist, 1984; Barclay, personal
communication). Moreover, cloning and sequencing of a gene coding
for a bifunctional DHFR-TS protein from 1. major was recently
reported (Coderre et ala ,1983; Beverley et al., 1986).
The mouse, human and Chinese hamster DHFR genes have been
extensively characterized. All three genes are relatively large)
comprising 34 kb of genomic DNA for the mouse gene, 30 kb for the
human chromosomal DNA and 26kb for Chinese hamster DHFR locus. In
general terms, all three genes have a similar overall structure,
i.e. they contain the same number of exons (six) which comprise a
561 bp nucleotide coding sequence for mouse DHFR and 564 bp for
both the human and Chinese hamster genes. All three genes contain
five introns, at equivalent positions within the coding sequence.
The different overall sizes of the three genes is attributable
mainly to the different lengths of their introns (Yang et al.,
1984).
Analysis of the regulation of expression of these mammalian
DHFR genes has revealed an previously unsuspected complexity. For
example, it has been shown that the mouse DHFR gene is expressed
as multiple mRNA species, consisting of four major and two minor
~ranscripts (Setzer et al., 1980; Farnham and Schimke, 1986a).
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Several of these mRNAs result from the use of different
polyadenylation sites, yielding mRNA molecules that differ in the
length of their 3' untranslated regions (Setzer et al., 1982;
Masters et al_, 1983). There is also apparent heterogeneity in
the initiation site for mouse DHFR gene transcription (McGrogen
et al., 1985; Sazer and Schimke, 1986). In human cells, three
main species and at least six minor species of DHFR mRNA have
been identified (Morandi et al.,1982; Masters and Addardi, 1985).
The three major species reflect the utilization of a single
transcription initiation site at the 5' end of the gene but three
different polyadenylation sites in the 3' downstream region. The
minor species can be accounted for as transcripts originating
from sites for transcriptional initiation several hundred
nucleotides upstream of the main mRNA start site (Masters et al.,
1983; Masters and Attardi, 1985). Although the Chinese hamster
transcription unit has not yet been as extensively characterized,
multiple transcripts have been observed. In common with the
previous studies, these seem to be related to the utilization of
different transcription initiation sites and polyadenylation
signals (Lewis et al., 1982; Carothers et al., 1983; Mitchell at
al., 1986).
In addition to the apparent complexity of DHFR transcription
initiation, functional analysis of the DNA sequence of the
mammalian DHFR genes has revealed several other distinctive
features of their promoter regions. Firstly, unlike most higher
eukaryotic genes studied to date, mammalian DHFR genes lacked
typical "CAAT" and "TATA" boxes upst1'geam from the t1"anscriptional
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initiation site. Alternatively, novel 29 bp conserved sequences
were found at a relatively fixed location 45 to 49 bp upstream of
each major transcription start site of the various genes. One
such conserved sequence was found in the human DHFR gene (Chen et
al.,1984; Yang et al., 1984); two repeats were located in the
Chinese hamster gene (Mitchell et al., 1986) and four similar
regions were seen in the mouse gene ( Crouse et al., 1982). Each
of these conserved sequences contained an identical HGC Il box
thought to be the binding site for the eukaryotic RNA polymerase
II transcription factor Sp1 (Dynan and Tjian, 1985). Another
novel feature of both the mouse and hamster genes was the finding
that the DHFR promoter functions bidirectionally, with
transcription occuring divergently on opposite DNA strands
(Farnham et al., 1985; Crouse et al., 1985; Mitchellet et al.,
1986). The significance of the bidirectionality of transcription
and the identification of the divergent gene product remain to be
eltl.cidated.
In addition to the interesting regulatory elements that have
been identified in their promoter regions, examination of the 3'
end of various DHFR mRNA species and the DNA sequence surrounding
the polyadenylation sites have indicated other novel features of
the transcription unit of DHFR genes (Setzer et al., 1982;
Masters et al., 1983). Thus, it has been reported that DHFR mRNA
transcription was terminated at multiple sites and that some of
the polyadenylation signals were located several hundred to
several thousand nucleotides downstream from the translation
terminator. Moreover, the canonical seq.uence "AAUAAA", thought to
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be the polyadenylation signal for most eukaryotic mRNAs is
lacking in many of these DHFR mRNA species. This suggests that an
alternative signal is required for the polyadenylation of the
mammalian DHFR mRNAs. A possible explanation for these unusual
features of the structure of various DHFR genes is that these
sequences might account for the observed complexity of the
regulation of their expression.
DHFR genes have been classified as "housekeeping" genes that
are normally constitutively expressed at a relatively low level.
Although expression of DHFR genes at a basal level seems
necessary for the intermediary metabolism of one carbon transfer
reactions, many studies have shown that intracellular DHFR levels
are responsive to a variety of modulators (Cowan et al., 1986),
such as viral infection (Kellems et al., 1979; Yoder et al.,
1983; Yoder and Berget, 1985), treatment with folate antagonists
(Chello et al., 1976; Domin et al~, 1982) or serum (Gudewicz el
al., 1981; Santiago et al., 1984). In addition, it has been shown
that, in common with a number of enzymes involved in DNA
replication and deoxyribonucleotide synthesis, the activity of
DHFR in mammalian cells is expressed periodically during the cell
cycle. Maximal DHFR activity occurred during S phase (Hillcoat et
a1., 1973; Alt et al., 1976; Johnson et al., 1978). Further
studies showed that the increase in DHFR level was due to an
increased rate of de novo DHFR synthesis rather than to
stabilization of the enzyme (Alt et al., 1976; Mariani et al.,
1981). Also, it is generally agreed among investigators in the
field that the increased rate of DHFR synthesis in S phase
in the rate of DHFR messenger production
an increase in the half-life of DHFR mRNA
1980; Leys and Kellems, 1981; Mullner et
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reflects an increase
rather than from
(Hendrickson et al.,
al., 1983).
However, the level at which DHFR mRNA producton is regulated
has been in dispute for a number of years. The main point of
contention is whether the rate of production of DHFR mRNA is
controlled by regulation of the rate of DHFR transcription, or by
modulation of transcript processing and/or export of the mature
DHFR mRNA from the nucleus to the cytoplasm. Both conclusions
have some support from the experimental data obtained to date.
In studies of the DHFR gene in stationary phase sarcoma 180
cells following replating at lower cell density, Leys and Kellems
(1981) showed that growth stimulation resulted in a threefold
increase in the rate of mature DHFR mRNA production. In addition,
these authors showed that this increase was not accompanied by a
corresponding change in the rate of transcription of the DHFR
gene. Subsequent studies (Leys et al., 1984) revealed that, in
stationary cells, most DHFR transcripts were rapidly degraded in
the nucleus, but there was no significant difference in the rate
of processing and transport of stable DHFR messenger. As a
consequence of these findings,- these authors concluded that
changes in the stablity of DHFR mRNA in the nucleus ultmately
controlled the amount of DHFR mRNA available for transcription in
the cytoplasm. Additional support for this view resulted from
similar observations in studies of amino acid-starved 3T6 cells
(Collins et al., 1983). Moreover, studies of the expression of a
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chimeric SV40-mouse DHFR eDNA gene introduced into DHFR deficient
Chinese hamster cells demonstrated that the increased irate of
production of DHFR mRNA in growing cells was not associated with
changes in the level of transcriptional activity (Kaufman and
Sharp, 1983). Furthermore 1 these studies showed that the 3'
noncoding region of the DHFR mRNA appeared to be involved in the
control of the conversion of DHFR hnRNA into mature mRNA, in
stationary phase cells. Thus, these experiments suggested that
DHFR mRNA production was controlled at the posttranscriptional
level during the cell cycle.
In contrast to these observations were other reports which
documented a good correlation between the rate of DHFR gene
transcription and the rate of cytoplasmic DHFR mRNA production in
serum-stimulated 3T6 cells (Santiago et al., 1984). A similar
conclusion was also reached during analysis of DHFR gene
transcription in mouse 3T6 cell populations synchronized in
different phases of the cell cycle (Farnham and Schimke, 1985)~
More recent studies have demonstrated that intracellular levels
of all of the mouse DHFR transcripts were maintained throughout
the cell cycle in a similar manner~ Thus, DHFR messenger levels
increased at the Gl/S boundary without significantly changing
their ratios relative to one another, in both the nucleus and in.
the cytoplasm (Farnham and Sckimke, 1986a). Furthermore,
transfection experiments with various DHFR minigenes have
revealed that the DNA sequence upstream from the transcription
site was required for this cell-cycle regulation (Farnham and
Schimke, 1986a).
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The observation that there was no differential utilization
of transcriptional initiation sites of the various DHFR mRNAs in
different phases of the cell cycle has led to the suggestion that
cell-cycle regulation of the DHFR gene may be mediated by a
transient increase in the general efficiency of transcription at
the DHFRpromoter. Thus, the periodicity of DHFR mRNA production
may reflect regulation ,by a transcriptional factor whose activity
changes as cells progress through the cell cycle (Farnham and
Schimke, 1985). Consonant with this view, Farnham and Schimke
(1986a) have since demonstrated the presence of a cell-cycle-
specific factor which stimulated transcription at the DHFR gene
in an in vitro transcription system. Additional experimental
support for the model has recently obtained by Dynan et aIM
(1986) who also have shown that the eukaryotic transcription
factor Spl can specifically stimulate transcription from the DHFR
promoter. However, the establishment of a definitive role for the
Spl factor in the cell cycle regulation of DHFR gene will still
require further investigation. Specific experiments are required
to determine whether the activity of Spl also exhibits a cell
cycle pattern and to isolate and characterize other factor(s)
which may interact with Bpi during the cell cycle. Whatever the
detailed molecular mechanism might be, the results described
above seem to indicate that the rate of production of DHFR mRNA
is controlled by at least two different mechanisms which respond
to the physiological state of the cell.
An additional feature of interest, with respect to DHFR gene
expression, is the possible role of an autoregulatory mechanism
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in the control of DHFR synthesis (Sirotnak, 1970; Calvo and Fink,
1971; Sirtnake and McCuen, 1973; Gronenborn and Davis, 1981;
Bastow et al., 1984). Experimental evidence which supports the
notion of autogenous regulation came from the finding that
treatment with subsaturating doses of MTX was shown to induce
intracellular DHFR activity by increasing DHFR synthesis rather
than by gene amplification. Thus, it has been proposed that MTX
or a metabolic derivative could prevent DHFR from exerting its
autoregulatory activity by altering the enzyme conformation or,
alternatively, by competing with a regulatory molecule (Bastow
et al., 1984). In this way, intracellular DHFR activity could
be controlled either at the transcriptional and/or post-
transcriptional level. Thus, feedback control could occur through
direct interaction of DHFR with its mRNA or with a DHFR-specific
DNA sequence. There is no experimental evidence that supports
the idea of an interaction of DHFR with its own message, but
there is some data which suggests that the 1. casei DHFR
protein has DNA binding acitivity, with a greater affinity for a
DNA sequence 5' to the DHFR structural gene (Gronenbon and Davis,
1981).
Although we do not have a complete picture of the various
elements which modulate DHFR gene expression, results to date
indicate that the control of DHFR expression is apparently quite
complex. In spite of a general lack of knowledge about detailed
molecular mechanisms, activity studies have begun to provide some
important insights into the control of DHFR expression. It is
clear that advances in our understanding of DHFR regulation will
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not only contribute to our basic knowledge about eukaryotic gene
expression in general, but, because of the importance of DHFR as
a target of many chemotherapeutic drugs, it is likely that such
knowledge will also be of some clinical utility.
Although DHFR proteins and genes from various organisms have
been studied in some depth, relatively little is known about the
enzyme or the gene which encodes it in the baker's yeast
Saccharomyces cerevisiae, which, as an experimental system,
has great technical advantages. In early experiments, by studying
the enzymatic defects in folate-dependent yeast auxotrophs,
Zelikson and Luzzati (1977) suggested that there are two parallel
sets of enzymes involved in folate coenzyme-mediated one-carbon
transfer. According to these authors, one set of folate enzymes
'is located in the mitochondria and the other set is found in the
cytoplasm. Among the THF interconversion enzymes studied was
DHFR. It is clear that such dual subcellular distributions of the
enzyme activity requires further experimental confirmation.
However, if supported by additional experimentation, these
results raise the interesting possibility that more than one gene
may encode DHFR activity in yeast or alternatively that a single
genetic locus may encode two DHFR activities. Although no DHFR-
yeast mutant has been isolated, the phenotype of which might
shed some light on this question, the wild type allele of the
gene (DFR1) has been isolated on a chimeric plasmid. The
selection scheme was based on the differential sensitivties to Tm
of the E.coli and yeast DHFRs (Nath and Baptist, 1984;
Barclay, personal communication). Preliminary studies using the
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cloned gene (Barclay and Nagel, manuscript in preparation) have
shown that no effect on host Tm sensitivity can be observed when
a plasmid harboring the DFRl gene is introduced into rad6,
rad18 (Game et al., 1975) or saline-treated RAD wild-type
yeast strains (Mayer and Goin, 1984). This was a somewhat
surprising result as there was a significant increase in
resistance to MTX, another DHFR inhibitor, in these strains grown
under similar conditions. These observations mentioned above were
virtually all that was known about yeast DHFR expression at the
beginning of this study.
It was my hope that the availability of many relatively
sophisticated methods in classical genetics which have been
developed in yeast over many years, combined with the more novel
and very powerful techniques in modern molecular biology, would
afford many technical advantages to studies of DHFR expression in
yeast. Two very useful techniques which have been developed in
recent years are gene fusion and gene disruption, or gene
transplacement.
Gene fusions were originally developed in prokaryotic
systems and since that time have been used with considerable
success in yeast. E.coli lacZ (encoding beta-galactosidase)
fusions have been most commonly used because of the many
advantages afforded in the construction of required fusions and
in the biochemical assay of their products. For example, assay
systems which are not only convenient but also extremely
sensitive have been developed for qualitative and quantitative
measurements of beta-galactosidase activity (Miller, 1972). In
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addition, it has been demonstrated that as many as 27 amino acids
at the amino terminus of the beta-galactosidase protein may be
replaced with other peptide sequences of varying length without
substantially affecting the activity of the enzyme (Brickman at
al., 1979)" Thus, the coding region of the lacZ gene can easily
be fused to a DNA sequence containing the translational start
codon and a promoter of interest as well as attendant 5'
regulatory elements, so that expression of the lacZ gene is now
under the control of the genetic regulator under study. Factors
affecting the level of expression of a particular gene of
interest can be monitored !by observing changes in beta-
galactosidase activity under various experimental conditions_
Thus, it has now become commonplace to engineer hybrid genes
between yeast genes and prokaryotic genes (such as the lacZ
gene) and to insert these fusions into shuttle plasmids that can
be moved back and forth relatively easily between E.coli and
yeast. Furthermore, studies from several laboratories have
demonstrated that the lacZ gene fusions are readily expressed
in yeast cells, which themselves have no inherent beta-
galactosidase activity (Rose et al., 1981; Guarente and Ptashne,
1981; Guarente, 1983). Because of their versatility and
resolving power, lacZ gene fusions have been employed in a wide
range of experiments in yeast, including studies of protein
localization, protein transport and gene expression. Studies of
gene fusion expression have been particularly valuable for the
detection of regulatory elements of genes and the molecular
signals which regulate gene expression, which may have been
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difficult to study by other methods~
In addition to gene fusion studies in yeast, other
techniques utilizing cloned genes have been developed, which
greatly facilitate the studies of genetic regulation in this
simple eukaryote. One of the more powerful techniques is the use
of integrating plasmids to mutagenize yeast chromosomal loci by
gene disruption or transplacement (Scherer and Davis, 1979;
Rothstein, 1983; Struhl, 1983; Boeke, 1984; Rudolph et al.,
1985). The basic feature of this approach is that any cloned
DNA fragment, after appropriate manipulation in vitro, can
be reintroduced into yeast cells and integrated into the
original locus through homologous recombination. There are many
useful applications of these gene disruptions or gene
transplacements. For example, once a cloned yeast DNA fragment
has been appropriately engineered, it can be used to alter or
delete completely a specific chromosomal region, thereby
introducing a mutant allele into a particular genetic background.
Thus, it would be possible to determine whether a gene has an
essential function in yeast, as such a disruption in the
heterozygous state would segregate 2:0 for the lethal phenotype.
Such studies employing the cloned DFRl yeast gene would greatly
improve our understanding of the role of DHFR in cellular
metabolism.
A long term objective of studies in our laboratory has been
to understand the genetics and biochemistry of pyrimidine
nucleotide and folate metabolism in yeast. Recently, it has been
shown that thymidylate stress has considerable genetic and
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biochemical effects (Barclay et al.; 1982, Kunz, 1982; Haynes,
1985). In yeast, depletion of thymidylate pools causes
ttthymineless death", and is highly recombinagenic for nuclear
genes and is mutagenic for the mitochrondrial genome (Barclay and
Little, 1978). Excess thymidylate is highly mutagenic for
nuclear genes (Barclay and Little, 1981). Several folate
antagonists such as MTX, sulfanilamide (SULF) and aminopterin
cause a depletion of the intracellular THF pools, which
ultimately results in "thymineless death" as well. One of the
difficulties in our attempt to understand the nature of the
genetic and biochemical effects of thymidylate stress is a
pauci ty of knowledge about the 1-'egulation of genes which encode
the enzymes involved in thymidylate and folate metabolism~ A very
important enzyme in this pathway is DHFR. Thus, knowledge of the
expression and regulatory mechanism of DHFR synthesis is
essential for our increased understanding of the regulation of
folate and pyrimidine nucleotide metabolism in this organism.
The availability of the cloned DFRl gene on a chimeric
plasmid enabled me to utilize the technical advantages of the
yeast system in studying the regulation of this gene. As a first
step towards the investigation of the regulation of DFRl
expression at the molecular level, it was necessary to
characterize the physical structure of the gene. It was thought
that identification of the coding region of the gene and its
continuous regulatory elements would be useful in the
construction of DFR1: lacZ gene fusions for use in furt11,er
studies of yeast DHFR gene regulation. Moreover, this information
32
could also be used for the construction of a gene disruption
vector to be used in the isolation of a DHFR-deficient yeast
strain, which would be valuable for biochemical and genetic
analysis of DHFR function. In spite of the fact that much effort
has been made in an attempt to isolate such a DHFR-deficient
mutant (Little, personal communication), to my knowledge, no such
mutant has been isolated by conventional classical techniques.
Thus, my thesis research began with the following
intentions:
(1) Determination of the primary nucleotide sequence of the
yeast DFRl gene and attendant regulatory elements.
(2) Construction of a gene fusion between the coding region
of the E.coli lacZ gene and the regulatory region of the
yeast DFRl gene.
(3) Construction of a DHFR-deficient yeast mutant strain
by gene disruption.
It was my hope that by a combination of these approaches, I
could develop useful molecular tools for more detailed
investigations of the regulation of DHFR gene expression in this
simple eukaryote.
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~ATERIALS AND METHODS
T. Enzymes and Chemicals
The large fragment of E.coli DNA polymerase I (Kle ow
fragment), restriction endonucleases, T4 DNA ligase and Ba131
exonuclease were obtainbd from Bethesda Research Labs, Inc.
Glusulase was purchased from E.I. du Pont de Nemoours & Co.
( II1C. ) ~ Zymolyase was supplied by Seikagaku Kogyo Co .. RNase T1
and RNase A were outained from International Biotechnologies,
Inc. DNA sequencing primer, nucleotide reagent~ and BamHl
restriction endonuclease 5' phosphorylated linker were purchased
from Pharmacia P-L Biochemicals, Inc. Radioactive compounds were
supplied by New England Nuclear Corp. All culture media reagents
were pure ased from Difco, BDH Chemicals or Bethesda Research
Other chemicals were obtained from Sigma Chemical Co~
or Pharmacia P-L Biochemicals, Inc.
II. Bacterial and Yeast Strains
E. coli. st1."ains used in t.11is Stl_1dy a:re listed ill Table 1.
The strain JF175~ provided by J. Freisen (University of Toronto)
was used as a host for all plasmids. Strains MC1064 and MC1066
(Casadaban et al. 983) were employed in gene fusion studies and
were also US9~ as hosts for the , sian plasmids. The bacterial
strain JM103 was ~urchased from uRL lebs., nc~ and was used in
M13 cloning and the gene~ation of single strand DNA templates for
DNP.l S\3 C1uenciYlg 5
Table 1. Bacterial Strains used in this study
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Strain
JF1754
MC1064
MC1066
JM103
Genotype
lac, gal, metB, leuB,
hisB436, hsdR.
6(lacIPOZYA)X74, galU, galK,
strA , hsdR , 6(ara,leu-),-
tl.~pC983r - -
6(lacIPOZYA)X74, galU, galK,
strA , hsdR , 6(~,leu),
trpC9830, pryF74::Tn5(Km ).
6(lac proA,B)/F' ,proA,B,
laclqZ M15, thi, strA,
sbcB15,-suI>E4"4: traD36,
hsdR4.
Source/Ref.
t-T. D. Freisen ..
Casadaban
et al., 1983#
Casadaban
et a1.,
1983.
Bethesda.
Research
Labs.
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The haploid yeast strain Ml/2B (Casadaban et al.,1983) was
used in both gene fusion and gene disruption studies. Diploid
strain TH4 was derived from a mating of strain LP272B-4B provided
by L. Prakash (Rochester University) with strain DS1/38 from this
laboratory CD.F. Steele) and was employed in gene disruption
studies. Haploid strain DBY747 was obtained from R.H. Schiestl
(Rochester University) and was used in gene disruption studies
(see Table 2).
III. Growth, Selectio~ and Assay Media
Preparation and composition of
medium and minimal (M9) medium were
bacterial complete (LB)
as described by Miller
(1972). When required in selective procedures, appropriate amino
acids were added to a final concentration of 50ug per ml~
Antibiotics were added to the media at 48-c after autoclaving or
spread on the plates to the following final concentrations:
ampicillin 50ug/ml, neomycin sulfate 200ug/ml, and trimethoprim
2ug/ml. The M9 minimal medium containing lactose as a carbon
source was employed in the plate assay of the beta-galactosidase
activities.
The yeast complex media (YPD) and synthetic minimal medium
(SD) employed in this study were those described by Sherman et
al.(1974). For preparation of the synthetic complete medium with
various constituents, appropriate amino acids, adenine and uracil
were added at the final concentrations suggested by Sherman et
al. (1974). Unless otherwise stated, folinic acid was supplied at
the standard level required for the yeast Fol mutant strains (ie.
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Table 2. Yeast strains used in this study
Strain
Ml/2B
IJP2729-4B
DBY747
Genotype
MATa, trpl-289, ura3-52.
MATa, his3-~1, leu2-3, leu2-112,
trpl-289 , ~3-52, rad18·-2.
MATa, trpl-289, ura3-52, leu2,
his3. --'
Soul:ce/Ref .
Casad.ahaIl et
al., 1983.
L.Prakash
DS1/38
T84
TH41-12
MATa, leu2-3, leu2-112, his4, D. Steele
iir"a:3-Sr
MATa/MATa , his3-~1/HIS3, HIS4/his4, This study
~2-3/1eu2-3, leu2=TI2/1eu2-112,
trpl-M289/TRP1, llra3-52/ura3--52,
rad18-2/RAD18. - -
MA'-.ea/MATa, 11.is3-~1/HIS3, HIS4/his4, ,This study
Ie'U2-3/1eu2-:3, leu2::-rT2/1eu2-1127
trpl·-289/TRP1, Llra3-52/ura3-52,
rad18-2/RAD18, ~1/URA3:dfrl.
TM12B MATa, trpl-289, ~3-52, tllp- . This stLldy
TDBY747 ~a, trpl'-289, ~3-52, leu2, This study
~3, tup-. -
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to a final concentration of 250ug per ml). Isolation of
dTMP-permeable yeast strains (~up mutants) was carried out on
the MTX-SULF-supplemented YPDP medium in which the YPD medium was
supplied with 1~5g KHZ P04per liter at 34°C (Little and Haynes,
1979). The presporulation and sporulation media were those
described by Sherman et al. (1974). Buffered synthetic selective
medium used for assay of beta-galactosidase was described by
Rose and Botstein (1983). Solid media was by addition of 2%
Bacto agar. Unless stated otherwise, all components were
sterilized by autoclaving for 20 minutes. To prepare buffered
synthetic selective medium for beta-gal assay, salts and agar
with sugar were brought to double strength and autoclaved
separately. After cooling to 55~C, the two solutions were
mixed, and the vitamins and 5-bromo-4chloro-3-indolyl-beta-D-
galactosidase (X-gal) were then added. Soft agar (regeneration
agar or top agar) was made by adding Bacto agar to liquid
media to a final consentration of 0.6%.
IV. Yeast Genetic Methods
Yeast mating, sporulation and random spore analysis were
carried out as described by Sherman et al. (1974).
The diploid strain TH4 was constructed by mating strain
LP2729-4B with strain DS1/38 and isolating the diploid through
complemention. Both haploid strains were grown on appropriate
synthentic selective media and then single colonies were
streaked on YPD medium. The streaks from each strain were
perpendicular so that the mating of two strains occured at the
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intersections. After 24 hr growth at 30 G C, the YPD plate was
replica plated on to omission plates. Several colonies growing
in the intersections of the two haploids were picked and
substreaked on another fresh SD plate for pure colony isolation~
Before use in the gene disruption experiments, several colonies
were tested to to confirm the ability of the diploid strain to
sporulate.
For sporulation, a single colony from selective SD plate was
transfered to presporulation medium. After two days, growth cells
at 30'C were transfered to a sporulation plate for another two
days. Sporulation was monitored by microscrope. For random spore
analysis of the diploid strain TH41-12 containing a heterozygous
disruption at the DFRl locus, cells from the sporulation medium
were suspended in O.2ml of a 1/40 dilution of Glusulase and
incubated with shaking for 1 to 2 hours. The treated asci were
diluted to 5ml followed by sonication for about 3 to 5 minutes.
Separation of spores from asci was monitored with a microscrope.
Spores were judged to be separated adequately when greater than
95% of the spores were released from the asci. After appropriate
several dilutions, O.2ml of each dilutions were plated onto YPD
plates. Emergent colonies were then picked and spotted on various
selective plates for determination of phenotype.
v. Selection of dTMP-Permeable Strains
mutants) were isolated as
(1979). YPDP
(100ug/ml)
dTMP-permeable strains Ctup
described by Little and Haynes
containing SULF (5mg/ml) and MTX
selection plates
were supplemented
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with dTMP (100ug/ml). Exponential cells were washed in O.lM
phosphate buffer (pH7.0) and plated to a final density of about
2xl07 cells/plate. After 5 days incubation at 34°c, the biggest
colonies were picked and retested. Tup mutants thus isolated
were used in the gene disruption and gene fusion studies.
VI. E.coli Transformations
The transformation of E.coli was done according to the
calcium chloride method of Mandel and Higa (1970). Competent
cells were used immediately in transformation experiments or
stored at 4°C for up to 24 h before use. For routine
"transformations, cells were spread on LB plates supplemented with
appropriate antibiotics. Plates were then incubated at 37~C
overnight. Transformants were then retested for antibiotic
resistance. For M13 bacteriophage transductions, cells were
plated with soft agar onto the L plates, according to the
procedure described by Pharmacia, Inc ..
VII. Yeast Transfections
The transfection of yeast was carried out essentially as
described by Hinnen et al. (1978) with modifications reported by
McNeil et al.(1980). Either glusolase or zymolyase was used to
prepare spheroplasts. Putative transfectants were scored after
incubation for 3-5 days at 30°C. Transformants were then picked
and retested on identical selection plates to confirm their
phenotype.
XIII. DNA Purifications
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Rapid isolation of covalently closed circular plasmid DNA
from E.coli for use in restriction map analysis as well as
bacterial and yeast transformations was done by the alkaline
lysis procedure described by Birnboin and Daly (1979). The DNA
samples were stored in TE buffer (pH8.D) which contained 10mM
Tris-HCl, lmM EDTA. If the sample was to be used for restriction
map analysis, it was first treated for 15 minutes at room
temperture with DNase-free RNase. The DNA sample could be stored
at - 20·C for up to two days. A' 1.5ml culture usually yielded
about 1 to 2.5 ug plasmid DNA.
If a purer plasmid DNA preparation was required, a large
scale purification was performed according to the cesium chloride
density gradient procedure described by Maniatis et al.(1982).
Plasmid DNA samples purified by this method could be stored at
4°C for at least one year without loss of biological activity.
Bacteriophage (RF) DNA preparation was conducted as
described by Barnes et al.(1983). This procedure is basically
similar to the large scale preparation for plasmid DNA except
that bacterial cultures were first grown in LB medium to
exponential phase and then infected with phage suspension. The
infected culture was used to prepare the RF DNA by the method
described above for a large scale preparation of plasmid DNA.
Single-stranded viral DNAs from recombinant M13mp18 and
M13mp19 phages were prepared according to the manual for M13
cloning and sequencing provided by P-L Biochemicals, Inc. with
minor modification. DNA samples were extracted sequentially with
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phenol, chloroform/phenol, and then chloroform alone.
IX. DNA Manipulations
(i) Restriction Endonuclease Digestion. Plasmid DNA
digestion with restriction endonucleases was performed in
appropriate digestion btlffers as- described by Maniatis eti a1.,
(1982) or as recommended by the manufacturers.
(ii) Ligation of DNA Fragments. Ligation of DNA fragments
was carried out in ligation buffer (50mM Tris-HCl pH7.6, lOmM
MgC1Z , 10mM dithiothreitol, lmM ATP) with T4 DNA ligase. For
routine ligation reactions (in a 20ul volume), 1 unit of the T4
DNA ligase was used for fragments with sticky ends while 5-10
units was employed for blunt ended ligations. Attachment of
synthetic phosphorylated linker (50ug/ml) to fragments with blunt
ends was performed as described for blunt-ended ligation.
Ligation mixtures were incubated at 148 C for 6 to 24 hrs.
(iii) Filling Recessed 3' Ends of Double-stranded DNA.
Filling recessed 3' ends of double-stranded DNA was achieved in
20ul nick-translation buffer (50mM Tris-HCl ph7.2, lOmM MgS~ ,
O.lmM dithiothreitol, 50ug/ml bovine serum albumin) containing
lmM dNTPs and 1 unit of Klenow fragment of i.coli polymerase
I for 30 minutes at 20 G C. The reaction was stopped by addition of
luI of O.5M EDTA.
(iv) Deletion of DNA Fragments with Ba131. Deletion of DNA
fragments was accomplished in exonuclease Ba131 buffer containing
12mM CaCl,2., 12mM MgCl;z.., 400nlM NaCl, 20mM Tris'-HCl pH8, lmM EDTA
and BSA (250ug/ml). As monitored on agarose gels, 1 unit of the
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Ba131 (from BRL) removed about 100 bases from each end of the
mixed fragments when about 7ug of the plasmid pIUD digested with
either restriction enzyme HindIII or EcoRl in 60 seconds. Ba131
reactions were stopped by addition of EDTA to a final
concentration of 25mM.
(v) Quantitation of DNA. For quantitation of DNA samples
the minigel method was used (Maniatis et al., 1982). The quantity
of DNA was estimated by comparing with a DNA standard. For DNA
samples purified by the large scale procedure, a spectrophoto-
metric method was also utilized and the ratio of optical
densities at 280 and 260 urn was used as a measure of purity. The
biological activity of the DNA sample was determined by its
bacterial transformation frequency.
x. Agarose Gel Electrophoresis
Agarose gels were prepared with TBE buffer (89mM Tris-
borate, 89mM boric acid and 2mM EDTA). The same buffer was
employed during electrophoresis. DNA samples were loaded in the
buffer described by Maniatis et al.(1982). Gels were stained with
ethidium bromide and DNA was visualized with UV light in a
Chromato-Vue Transilluminator (Model TM-15). Photography of the
stained gel was conducted by using Polaroid High Speed 4x5 land
film (Type 57). This general method of agarose gel electro-
phoresis was used for restriction map analysis of recombinant
plasmids, identification of DNA fragments, and separation and
purification of DNA fragments required for the constructions of
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various recombinant plasmids.
XI. Recovery of DNA fro~ Agarose Ge}s,
The electroelution method described by Maniatis et al. (1982)
was adopted. After separation of a particular fragment from the
others in agarose gels after electrophoresis, a gel slice
containing the band of interest was cut out and placed into a
dialysis membrane filled with TBE buffer. The DNA was then
electroeluted from the gel slice into the dialysis bag in an
electrophoresis tank. DNA in the solution was thus purified by
phenol/chloroform extraction and recovered by ethanol
precipitation.
XII. Plasmid Constructions
Vectors and plasmids used or constructed during the course
of this study are given in Table 3. Plasmid pIUD-l (constructed
by M.Nagel in our laboratory) was used as a donor of the cloned
yeast genomic Sall/BamHl restriction fragment, containing the
DFRl gene. It was also employed in the constructions of
DFR1:LacZ fusions. Plasmid pLG669-Z (Guarrente and Ptashne,
1981) was used in the construction of the DFR1:LacZ fusions
and was the donor of the HindIII restriction fragment containing
the yeast URA3 gene. Both plasmid pSV2-neo (obtained from BRL)
and pYF91 (obtained from J.D. Freisen's lab. University of
Toronto) were employed in the construction of plasmids used in
gene disruption experiments. Plasmid pND21 (constructed by V.
Table 3. Vectors and Plasmids used in this study
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Plasn1id
plUDl
pLCi669-Z
pSV2-neo
pYF91
pDN21
Yip5
pNFIO-l
pNBD-2
pNBU-3
pDEH-5
pLBB20
pHBB200
pDSB1-Z
pEFZ-l
pEFZ-2
pEFZ-3
pEFZ-4
pEFZ-5
pEFZ-6
pEFZ-7
pEFZ-8
Characteristics
Ol.... i, Apr, URA3, DFR1_
ori, ApY, URA3, 2u, CYC1: lacZ fusion ..
o1-.i, AJ2.'Y, SV40ori, neo
ori, AEY , SV40ori, neo , DFR1.
ori, Apr, URA3, Tc
ori, ApT, SV40ori, n£Q
ori, ApY, SV40ori, neo , DFR1 ..
ori, AEY , SV40ori, ~ , URA3:dfrl.
ori, Apr, URA3, Tel", dfrl (65 tJ ,3' ) .
ori, :b:£Y, URA3, dfrl (63') ..
£E..i:., Apr, 2u, URA3, DFR1, 'lac-Z.
ori, Ap~, 2u, URA3, DFR1:1acZ fusion
ori, ApY, 2u, URA3, DFR1:1acZ fusion.
ori, Ap~, 2u, URA3, DFR1:1acZ fusion.
ol."i, Apr', 2u, URA3_z DFR1: lacZ fusion.
ori, Ap"', 2u, URA3, DFR1:1acZ fusion ..
ori, .!l£.y., 2u, URA3, DFR1: lacZ ftlSion.
ori, ApY, 2u, URA3, DFR1:1acZ fusion ..
ori, Ap"', 2u, URA3, DFR1:1acZ fusion.
SOul....ce/ref.
t'1. G. Nagel
L . Gllarrente
BRL.
J . I'. Fl.~eisen
V. BarcIa:>"
J .. D.Freisen
This study
T11i s s t.udy
Tl1.is study
This stLldy
Tl1.is sttldy
This study
This study
This study
This study
This study
This study
This st1.1dy
This study
45
Table 3. (cont'd)
----~~~~-------~--~--------------~-------------~----~---~--~-~-~-
Plasmid Cl-la.l-'acteri st i c s Sou1~ce/Ref .
--~--~-~--~---~~--~------------------~--~~-~--~-~--------~-~--~~-
pEFZ-9 o1~i , ApY
.1 2u, URA3, DFR1: lacZ fusiorl. Tl1.i s study
pEFZ ..-l0 ori, Apr , 2u, IJRA3, DFR1=lacZ fllsion .. This s·tudy
pEFZ'-11 ori, ApY , 2u, URA3, DFR1:1acZ fusiorl. This study
pHFZ'-l ori, ApY I), 1 URA3, DFR1:1acZ fL1Siol1. This st'u.dy, ~,
pHFZ~-2 o1-.i, ApY , 2u, URA3, DFR1: lacZ fusion,. Tl1.i s study
-'
pHFZ-3 ()1."t i , ApY 2u, URA3, DFR1:1acZ -F • Tl1.i s study, .USlon ..
pHFZ-4 ori, ApY, 2u, UR-,~3, DFR1:1acZ fusion. This stud.y·
pHFZ-5 ori, Ap~ , ?u URA3, DFR1: la,cZ fusion. This S·tlldy::::--'
pHFZ-6 ori, AP: , 2u, URA3, DFR1: lacZ fusion. This stu,dy
pHFZ-7 ori, Ap"'" , 2u., URA3, DFR1:1acZ fusion. This S·tlldy
pHFZ-8 ol.-.i, ApY, 2u, URA3, DFR1: lacZ fusion. Tl1.is study
pHFZ-9 01."I)i, ApT, 2tl, URA3, DFR1=lacZ fusion. Tllis study
pHFZ-1O ori, ApY, 2u, URA3, DFR1: lacZ fusion. This study
pHFZ-l1 ori, ApY, 2u, URA3, DFR1:1acZ fusion .. This study
pHFZ-12 ori, ApY, 2u" URA3, DFR1: lacZ fusion. This study
pliFZ-13 ori, Ap'Y , 2u, URA3, DFR1:1acZ fusion. Tl1is study
pHFZ-··14 ori, ApT, '?u URA3, DFR1: lacZ fusion. This study!:.:...-...'
pI-IFZ-15 ori, Ap"" , 2u URA3, DFR1=lacZ fusion. This study
-'
pHFZ-16 ori, ApY, 2u, URA3, DFR1: lacZ fu.sian, . This study
pHFZ-17 o1.'IIi, ApY, 2Ll, URA3, DFR1: lacZ fusion. Tl1.is st'Lldy
pHFZ-18 ari, .A12y , 2u, URA3, DFR1: lacZ fusion .. Tl'li s study
-----------------------------------~------~----------------~-----
Table 3. (cont'd)
PlaSlnid Characteristics
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Source/Ref ..
M13mp8B13 H HindIII/BamHl fragment in M13mp8
M13mp19EH EcoRl/HindIII fragment in M13mp19
M.G"Nagel
This study
~113mp19EB
M13mp18HS
M13mp19SH
M13mp18FIO
M13mp18F12
M13mp18F19
M13mp18F52
M13mp18S3
M13mp18F8
M13mp18F6
M13lnp18F3
M13n1p18Fl1
M13mp18F4
M13mp18F9
M13mp18F37
M13mp18F22
M13mp18S6
M13mp18F38
EcoRl/BamHl fragment in M13mp19
HindIII/Sall fragment in M13mp18
Sall/HindIII fragment in M13mp19
149bp Sau3A fragment (5'to 3') in mp18
149bp Sau3A fragment (3'to 5') in mp18
260bp Sau3A fragment (5'to 3') in mp18
260bp Sau3A fragment (3'to 5') in mp18
60bp Sau3A fragment (5
'
to 3') in mp18
60bp Sau3A fragment (3'to 5') in mp18
l05bp Sau3A fragment (5'to 3') in mp18
105bp Sau3A fragment (3'to 5') in mp18
60+128bp Sau3A fragments (5'to 3')
in mplB
128bp Sau3A fragment (3'to 5') in mp18
139bp Sau3A fragment (3-to 5') in mp18
525bp Sau3A fragment (5
'
to 3') in mp18
525bp Sau3A fragment (3'to 5') in mp18
238bp Sau3A fragment (5 ' to 3') in mp18
238bp Sau3A fragment (3'to 5') in mp18
This Stlldy
This study
This study
This study
TI1.is study
This stlldy
This st,lld.y
Tllis study
This stlldy
Tl1.is study'
This study
This study
TIl-is s·tudy
This study
This study
Tl1.is study
This stl.ldy
This study
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Barclay in this laboratory) was a donor of the BamBi restriction
fragment containing the DFRl gene~ Plasmid Yip5 was used as a
vector for insertion of an EcoRl/HindIII restriction fragment of
the internal fragment within the coding regiion of DFRl gene.
The following plasmids were constructed during the course of
gene disruption experiments. Plasmid pNHO-l was derived from
pSV2-neo by filling in its unique HindIII site. Plasmid pNBD-2
was then constructed by an insertion, into the unique BamHl site
of pNHO-l, of a BamHi restriction fragment containing DFR1,
isolated from plasmid pDN-21. Plasmid pNBU-3 was obtained by
insertion of a HindIII restriction fragment containing a URA3
gene, isolated from plasmid pLG669-Z, into the unique HindIII
site of the plasmid pNBD-2. Plasmid pDEH-5 was produced by
replacement of its smaller: EcoRl/HindIII restriction fragment
with an internal sequence within the coding ,region of the DFR1.
Plasmid pLBB20 was derived by insertion of a BamHl restriction
fragment containing DFR1, into the unique BamHl site of plasmid
pYF91.
To construct the pEZF plasmids, approximately 7 ug of
plasmid pIUD-l DNA was first digested with 30 units of EcoRl
restriction enzyme at 37°C for two hours. The DNA sample was then
extracted with phenol to move proteins and recovered with
ethanol. The DNA pellet was ,dissolved in 100 ul of 500ug/ml
bovine serum albumine solution and 100 ul Of 2 x Ba131 buffer
(24mM CaC12, 24mM MgCl~, 800mM NaCl, 40mM Tris-HC1(pH8.0), 2mM
EDTA) to a final concentration of about 33ug DNA/mI. One unit of
exonuclease Ba131 (BRL) was added to the solution and the
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'reaction mixture was incubated at 25°C. The extent of the
reaction was monitored by running a small amount of sample on
0.7% agarose gel. Under these conditions, the enzyme removed
approximately 100 bp from each end per minute. After 30 and 45
seconds of incubation, 100 ul aliquots were removed from the
reaction mixture and the Ba131 reaction was terminated by
addition of EDTA to a final concentration of 25mM. The samples
were pooled and the DNA
precipitated with ethanol.
stranded DNAs which were
was then extracted with phenol and
The recessed 3'-ends of the double-
left after treatment with Ba131 were
repaired in 20 ul of Klenow fragment buffer by reaction with one
unit of Klenow fragment of E.coli DNA polymerase I at 25°C
for 30 min. The reaction was stopped by addition of 1 ul of 500mM
EDTA. After phenol extraction and ethanol precipitation,
attachment of synthetic oliganucleotide Bam linker onto the blunt
ends was carried out in 20 ul of ligation buffer. 1.5 ug of
phosphorylated BamBi linker (BRL) and two units of T4 DNA ligase
were then added. The mixture was incubated at 14Q C overnither.
After phenol extraction and ethanol precipitation, about 5 ug of
the DNA sample was digested with excess amount of restriction
enzyme BamHl (200 units) for 5 hours to ensure the generation of
the BamHl sticky ends from the attached Bam linker. Proteins were
again removed by phenol extraction and the DNA sample was
recovered by ethanol. Digestion with restriction enzyme SaIl was
then performed to release the novel Sall/BamHl fragments in which
the 3' end of the coding region of the DFRl gene had been
deleted. The fragments of interesting fragments were then
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separated from the linker and other DNA fragments by agarose gel
electrophoresis and purified by electroelution. One-third of the
recovered DNA was used to ligate into the purified Sall/BamBl
restriction fragment of pLG669-Z. This ligation mixture was then
used to transform the E.coli LacZ mutant strain MC1064.
Transformants with potential fusion plasmids were selected on
Amp-LB agar plates containing X-gal.
The procedure used in construction of pHFZ fusion plasmids
was basically same as in the construction of the pEFZ fusion
plasmids described above, except that plasmid pIUD-l was first
digested with restriction enzyme HindIII rather than with EcoRl.
This was to make the deletion end points much closer to the
-translation initiation site of theDFRl gene than those in ·tlle
pEFZ fusions~ For the similar reasons, the reaction time of Ba131
digestion was increased to between 45 and 60 seconds, to come
close to the terminus of the DFRl cofing region. In addition,
after attachment of the BamHl linker and complete digestion with
restriction enzyme BamHl to generate the BamBi sticky ends from
the attached BamBi linker, the fragments of interesting were
separated by agarose gel electrophoresis and purified from the
gel. The molecules were then recircularized in a ligation
reaction and amplificated in E. coli. Over 200 colonies were
pooled and plasmid DNAs (pHBB200) from this mixed culture were
then purified by the large-scale procedure. These changes
provided much more of the Ba131-generated DFR1' fragments
which greatly facilitated the final construction of pHFZ
fusions. The original cloned Sall/BamHl genomic DNA fragment
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containing the intact DFRl gene was also inserted into the
vector pLG669-Z (resulting in plasmid pDSB1-Z) for use as a
contral plasmid in fusion experiments.
Bacteriophage M13mp18 and M13mp19 were used in subcloning of
the yeast DNA fragment to be sequenced. Plasmids constructed and
used during the course of sequencing the cloned Sall/BamHl yeast
genomic DNA fragment are summarized in Table 3. The Sall/HindIII
segment was cloned in both orientations into both M13 vectors.
The EcoRl/HindIII and EcoRl/BamHl segments were force-cloned into
M13mp19.. The other contl....Llctions were obtained by $I S}lotgun"
cloning a pool of Sau3A restriction segments generated by the
digestion of the purified SaIl/BamBi segment with restriction
enzyme Sau3A into M13mp18~
XIII. Anal~sis of Recombinant DNAs
Characterization of recombinant plasmids was carried out in
two ways. in vivo approaches were used if recombinant
plasmids were able to confer a different phenotype upon their
bacterial host (ie. resistance to antibiotics, and prototrophy or
auxotrophy for certain nutrients). In the case of Tm resistance,
bacterial transformants were first selected as Amp resistant.
Emergent colonies were then transfered to M9 selection plates to
score for Tm resistance. Once a potential recombinant plasmid was
identified by this in vivo approach, it was then analysized
by restriction enzyme digestion and agarose gel electrophoresis.
M13 recombinant molecules containing insert fragments for
sequencing were recognized as clear plaques on agar plates
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containing IPTG (Isopropyl-beta-D-thiogalactopyranoside) and
X-gal as described by Pharmacia. Size of the inserts was
determined by analysis of the migration of the single stranded
viral DNA (ssDNA) derived from clear plaques on agarose gels.
M13mp18 or M13mp19 ssDNA was 'used as standard. In the case of M13
recombinants
orientations
derived
of the
from Sau3A
inserts was
shotgun cloning,
determinated by
the
the
complementation (C-test) on agarose gels according to procedure
described by Barnes et alw (1983).
XIV. DNA Sequencing
The Sanger dideoxy chain termination method (Sanger et al.,
1977) was utilized in determination of the nuclsotide sequence of
the cloned yeast genomic DNA. The hybridization of primer and
template, and the dideoxy chain termination reactions were
performed essentially as described in the M13 cloning/sequencing
manual suppled by P-L Biochemicals, Inc .. The products of the
sequencing reactions were denatured by heating by boiling for 3
min. and resolved on 8% polyacrylamide/8M urea gels with running
times of 2 and 8 hours. After the electrophoresis was completed,
the gel was exposed to Kodak XAR-5 film at -70~C for 1 to 3 days.
The film was developed in Kodak GBX developer for 2 to 5 min. and
fixed in Kodak GBX fixer for 5 min .. Base sequences were read
directly from the autoradiographed film. A computer program (U of
MIND. Sequence Analysis Programs, Version 2.1, 1982) was used for
storage and analysis of the DNA sequence data.
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xv. Beta-galactosidase Assay
(i) Plate assays. Bacterial transformants containing
putative fusion plasmids were spotted onto LB-Amp agar plates or
M9-1actose agar plates, containing either 40ug/ml or 200ug/ml of
X-galt Yeast transformants were selected on SD medium and,
5ubs'equently, spotted on buffered SD medium (pH7.0) containing
200ug/ml of X-gal. For more sensitive detection of beta-
galactosidase activities in yeast colonies, the filter
permeabilizing method suggesed by Casadaban et ale (1983) was
used.
(ii) Culture assay. Bacterial assay for beta-galactosidase
activity was performed as described by Miller (1972). Yeast
transfectants were assayed by two methods. The permeabilized cell
method employed was essentially as described by Guarente and
Ptashne (1981) with the modifications suggested by Ruby et al.
(1983). The crude cell lyzate method used was that described by
Rose et al. (1981). Protein was measured by the Lowry method.
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RESULTS
Before this study began, the yeast DHFR gene (DFR1) had
been isolated on an 8.8 kb Bam Hi restriction fragment from the
J. Freisen yeast genomic library pYF94 by selection of E.coli
transformants resistant to trimethoprim (Tm) (Barclay et al.,
manuscript in preparation). The gene was subsequently localized
on an 1.7 kb SaIl/Bam Hi restriction fragment which when cloned
in either orientation into multicopy or integrating vectors
resulted in increased MTX resistance in yeast. The degree of drug
resistance was dependent upon the gene copy number (see Fig.2).
Further evidence that this fragment encoded the yeast DHFR was
obtained by G. Wahl who showed that plasmids containing the
putative cloned DFRl gene complemented an E.coli DHFR-
deficient mutant strain (G. Wahl, personal communication). These
observations suggested that the cloned 1.7 kb SaIl/BamBi
restriction fragment contained the yeast DHFR structural gene and
regulatory elements, which allowed for DFRl expression both in
E.coli and in yeast. Hence, this restriction fragment was
used in more detailed investigations of the structure and
regulation of the yeast DFRl gene.
I. DNA Sequence Analysis of the SaIl/BamBi Restriction
Fragment Containing the Yeast DFRl Gene
The DNA sequence of a gene provides useful information about
the physical properties of the gene product, such as, the amino
acid sequence and molecular weight of the encoded polypeptide. In
addition, such sequencing information can be used to identify
Figure 2 DFR1--mediated resistance to antifola·tes
(A). (): JF1754/pLG669-Ztt= JF1754/pDSB1-Z
Bacterial cells harboring the plasmids were grown in
LB medium containing 50ug/ml of Amp, for overnight. Cells
were washed once with M9 medium and resuspended, at a' cell
density of about 0.2 of OD at 600nm, in the M9 media
containing Met, His, Leu and various consentrations of Tm
(0, 5, 20, 50, 75 and lOOugjml). After 24h s~bsequent
culture, the growth was indicated by OD values at 600nm.
(B) . (): Ml/2B/pLG869-Z
~: Ml/2B/pIUDltt: Ml/2B/pDSB1-Z
Yeast cells containing the plasmids were grown in SD
medium containing Trp (20ug/ml), to about l06cells/ml.
Exponential cells were harvested by centrifugation and
resuspended in SD medium supplemented with SULF (5mgjml) and
MTX at various concentrations_ After 24h incubation at 30°C,
the cells densities were determined by a Coulter counter.
Structure of the plasmids is shown in Fig. 10.
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potential regulato~y elements continguous to the coding region
by comparison of these sequences with canonical structures
identified from other genes as having some important function in
gene expression. Besides providing useful information about the
gene product, which can be obtained directly from the sequencing
data, more importantly, such detailed information is extremely
helpful in the construction of various molecular tools to be used
and the design of experiments to investigate gene function and
regulation at the molecular level.
Modern methods for DNA sequencing fall into two broad
catagories: the primed synthesis method developed by Sanger et
al. (1977) and the chemical method developed by Maxam and Gilbert
(1977). The first method employs a primed DNA synthesis approach
in which a single stranded template which contains the sequence
of interest is copied to produce a radioactively labelled
complementary strand. By the use of the chain-terminating
inhibitors, 2',3' dideoxynucleoside 5' triphosphates, sets of
partially elongated molecules are produced, which can be
fractionated on denaturing electrophoresis gels. The patterns
of labelled bands obtained are then used to deduce the primary
base sequence. Highly efficient procedures have been developed
for the generation of single stranded templates from any cloned
duplex DNA utilizing the bacteriophage M13, which has given rise
to a broad adoption of this method for DNA sequencing. Because of
the ease with which the system can be utilized, the Sanger
dideoxy chain terminator methodology combined with the M13
cloning system has become· increasingly popular in recent years.
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Some sequencing data of the DFRl DNA fragment had been
obtained previously by Michael Nagel in our laboratory (M. Nagel
M.Sc. Thesis, Brock University, 1985). However, the data obtained
by the beginning of this study were somewhat limited. Thus, to
facilitate further studies on DFRl gene regulation, I began
this study by sequencing the Sall/BamHl restriction fragment
containing the DFRl gene in its entirety.
A. Nucleotide Sequence of the Sall/BamHl Restriction Fragment
Containing the DFRl Gene
The strategy employed in sequencing the DFRl gene is shown
in Fig. 3. The nucleotide sequence data shown in Fig. 4 are the
combined results from the analysis of various segments of the
Sal1/BamHl restriction fragment. As shown, within the fragment
which comprises a total of 1784 bases is a single open reading
frame of 633 bp, extending from residue 800 to 1432. This coding
region is sufficient to encode a polypeptide of 211 amino acids,
with a predicted molecular weight of 24,229.8 Daltons. The
region proximal to the ATG codon, tentatively assigned as the
translation initiation site of the DFRl gene (at position 800),
is in good agreement with that suggested as the prefered
environment of translation initiation sites of many eukaryotic
genes (Dobson et al., 1982; Kozak, 1984), i.e., an A is usually
found at position -3, a G at +4 (yeast) and a T at +6 (higher
eukaryotes) with respect to the ATG codon at position 1. Also
consistent with this assignment is the finding that the sequence
upstream of the ATG codon shows several features of promoter
Figure 3 Sequencing strategy for the 1.7 kb DFRl DNA
fragment
M13 cloning was as described previously in Methods. The
horizontal lines with arrowheads indicate the length and
direction of the sequenced M13 clones. The extent of the
DFRl open reading frame is indicated at the top of the
fiqure. Abbreviations for restriction sites are as
following: B, BamHl; P, Pstl; E, EcoRl; Pv, PvuII; H,
HindIII; S, SaIl; sa, Sau3A.
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Figure 4. Nucleotide and predicted amino acid sequence of
t.he DFEl gene
Potential "TATA li boxes are underlined ..
with the core sequence required for
control are marked by wave underline.
Homologous sequences
general amino acid
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TRANSLATION OF DFRl
2 -
TCGACGTACTTCAGTATGTAATATACCCCAAACATTTTACCCACAAAAAACCAGGATTTGAAAACTATAGCATCTAAAAG
82
TCTTAGGTACTAGAGTTTTCATTTCGGAGCAGGCTTTTTGAAAAATTTAATTCAACCATTGCAGCAGCTTTTGACTAACA
162
CATTCTACAGTAGGATCATTTC~ATAGGAATCGTCACTCTTTGACTCTTCAAAAGAGCCACTGAATCCAACTTGGTTGAT
IIIllI
242
GAGTCCCATAACCTTTGTACCCCAGAGTGAGAAACCGAAATTGAATCTAAATTAGCTTGGTCCGCAATCCTTAGCGGTTC
GGCCATCTATAATTTTGAATAAAAATTTTGrTTTGCCGTTGCATTTGTAGTTTTTTCCTTTGGAAGTAATTACAATATTT
402
TATGGCGCGATGATCTTGACCCATCCTATGTACTTCTTTTTTGAAGGGAT.".GGCCTCTATGGGTGGGTA(:AAATGGCAG T
482
CTGACAAGTTAACCACTTTTT'J'C(~'f1'TTCT AAA TTG TTTAAAA CC AAAC;GTTTGG TTTTCAG11TAAG AAA TTGGATTAG T
562
TGG TGTGTAAGTATAATTAI\ATnTAGTCTTGGTTAGCTTAATGTATAGGTTCTTGATAGTATGACTCCAceTAAAATTCG
...,.
642
TCAAGAGCGACGGATGCGAAAACAAAAAAATCGCTTTGCATCCTTACGTGCGTGAGATGGCATCGCTGGCCAAAGGGAAA
722
rOTTTCATTATTTTCTGTAGTTAArATTATGCTTTGCATGATAATAAGAGAAATTGAAGAGCGCAACGAACTACGAGC
800
MET ALA GLY GLY LYS ILE l·)HO If,F: VArJ nLY ILE VAL ALA CY::?, LEU GLN PRO GLU MET GLY
ATG GeT GGA GGA AAG ATT ceT 1\1'T GTA GGA ATT GTG GCA 1'GT TTA CAG CCG GAG ATG GGG
860
ILE GLY PHE ARG GLY GLV LEU PI~.(} TRP I\H.G LEU PHO :?JER GLtJ MET LYS TYR PHE AHG GLN
ATA GGA TTT car GGA GCT eTA CCA TGG AGG TTG cee AGT GAA ATG AAG TAT TTC AGA CAG
920
VAL THR SER LEU THR LYS A:;P PHO A~)N LYS LY::'; ASN ALA LEU ILE MET GLY ARG LYS THE
GTe ACT TeA 'rTG Ace AAA CAT CCA AAC AAA f\AA AAT GCT TTG ATA ATG GGA AGG AAG ACA
980
TRP GLU SER ILE PRO PHO LYS PHE ARG PHO LEU PRO ASN ARG HET ASN VAL ILE ILE SEh
TGG GAA Tee A1'A ceG cee AAG rrTT CGC CCA eTG ccc AAT AGA ATG AAT GTC ATT ATA TeG
59
1040
ARG SER PHE LYS ASP Af3P PHE VAL HIS. 1\GP LYS GLU ARG SER ILE VAL GLN SER ASN SEH
AGA AGe TTC AAG GAC GAT 'rTT GTC CAe GAT AAA GAG AGA TCA ATA GTC CAA AGT AAT TCA
1100
LEU ALA ASN ALA ILE MET ASN LEU GLU SER ASN PBE LYS GLU HIS LEU GLU ARG ILE TYF\
1TG GCA AAC GCA ATA ATC AAC eTA GAA AGe AAT TT1' AAG GAG CAT eTG GM AGA ATC TAe
1160
VAL ILE GLY GLY GLY GLL) VAL TYH f)ER GLN ILE PBE ~3ER ILE THR J\SP HIS TRP LEU I LF~
GTG ATT GGG GGT GGe GAA GTT TAT AGT CAA ATC TTC Tee ArT ACA GAT CAT TGG eTC ATC
1220
THR LYS ILE A~3N PRO LEU A:-;P LY~:I A~~~,N ALA THR PHO ALA MET ASP THR PHE LEU A~~,P ALA
ACG AAA ATA AAT CCA TTA GAT AAA AAC GCA ACT eel GCI\ ATG GAC ACT TTC CTT GAT Gce
1280
LYS LYS LEU GLU GLU VAL FBE C~Er{ CiLll GLtJ A:.:P PRO ALA GLN LEU LY~'; GLU F'HE LEU F'k('
AAG AAA TTC GAA GAA GT1\ TTT AGe GAG CAP. GAT ccc; Gee CAG eTG AAA GAA 'TTT crT cc,~·
1340
PRO LYS VAL GLO LEU Pft'.O GLU THH l\~;P eYE A:~.P nLN ARG TYH :;ER LEU GLtJ GLU LY~-; GLY
ceT AAA GTA GAG TTG CCC GILA, I\Cl\ GAC TGT GAT CAA cue TAe TCG eTG CiAA GAA AAA G<}T
1400
TYR CYS PHE GLU rHE TBH LEU TYR. /\.SN ARC LY~·; @@@ AA~CTCTCCGCCCGTATATTTTTTTTAATAT
TAT TGC TTC GAA TTC ACT eTA T/'le AAT CCT A/\A TGA
1467
GTTAAATAGTGATAGAACTGATAAGCCTCATTTTCTTTTATTGGGCTCCAAGACGCGAACTGTTCGTAGGGTAACCGTTT
1547
GAGACCTAAACGACCTTTCAGCCTCACCTGCAGTATTTCTTCAACAACGCCTGTCGCTATGTTAAATAATAGCAATCGTT
1627
TGTGATCACCATTGTCGAATTTGACGCGCTTAAACCAAAAACrATTGTTTTGGCCTCGTTCCCTGCATTCAACAAAAGAG
1707
CAAGGTATGCCGTCAAACAGTCGTTAAAAGAGAAGGTTTATAAACTATCTTGTTT~3TACTTTGCTGTCCCGGATCC
1784
THE MOLECULAR WEIGHT OF THIS f'r;~OTEJ N IS 24 2 :-~ ~~ . 8
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elements found in other yeast genes (see Results I, Section C).
Several sequences downstream of the putative translational
termination codon TGA (at position 1433) are in good agreement
with those which are highly conserved in several transcription
termination sequence elements in yeast (see Results I, Section
C). A comparison of the amino acid sequence deduced from the
assigned DFRl coding region with those of DHFR proteins
determined previously from various organisms reveals that
conserved sequences are located throughout the polypeptide (see
Results I, Section E). Further evidence that this assigment was
correct was obtained in experiments described later in this study'
(see Results V), in which a HindIII restriction fragment
containing the functional yeast URA3 gene was inserted into an
analogous restriction site within the putative coding region. A
host bacterium containing this plasmid construction remained
sensitive to Tm. This result suggested that the DFRl had been
disrupted by the URA3 DNA, consistent with my putative
assignment of the DHFR coding region. Furthermore, functional
expression in yeast of the two classes of DFR1: lac'Z fusions
constructed later in this study is also in agreement with such an
assignment.
c. Regulatory Sequences of the DFRl Gene
Most eukaryotic regulatory sequences located 5'to structural
genes can be divided into several distinct regions based upon
their presumed function during gene expression. These include the
tJranscriptional initiation site (I), the tlTATA" box and upst.l"eam
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regulatory elements (Benoist and Chambon, 1981; Guarente,1984;
Serfling et al. ,1985). In multicellular eukaryotes, the HTATA u
box is thought to direct the eukaryotic polymerase II to initiate
transcription at a discrete site, which is usually located about
30 bases downstream. In most cases, there seems to be no other
specific sequence requirements at this site for transcriptional
initiation (I site). In common with higher eukaroyotic cells, a
"TATA" box has been found in the 5# flanking sequences of most
yeast genes examined to date. However, in contrast to
observations made in multicellular eukaryotes) the distance
between tl1.e yeast "TATA" box and tIle I site is quite val.~iable,
ranging from 35 to 180 nucleotides (Sentenae and Hall, 1982).
Moreover, it has been shown that transcriptional initiation in
yeast often occurs at or near a sequence idential or closely
related to "CAAG" or llTCAA". In addition, a C-T rich block is
usually found up,stream of the nCAACi" sequeJ1Ce in genes wl1.ich are
expressed COIlsti tutively at a high level (Holland and Elolland.,
1980; Montgomeryet al,1980; Dobson .at al.,1982; Burke, 1983;
Hahn et al.,1985).
A search for these canonical sequences in the 5' ~lanking
region. of the DFRl gerle identified tl1.ree potential lITATA" box.es
at position -473, -227 (TATAAT) and -37 (TAATAA) with respect to
the assigned translational initiation site. The canonical
sequences lITCAAG" occurs 63 bp downstream of t11e tlTATAAT tl
sequence. An interesting feature of this sequence is that it
represents an overlap of the canonical regulatory signals
"TCAA" and "CAAGIt. Another "CAAG" sequence apperaes downstl.~ean1 of
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the sequence "TATAAT" (at -473). Several of the yeast.
sequence "CAAG" are found immediately downstream of
"TAAT.AA" _
of these
consens'us
the
the other
to several
were observed
contrast
blocks
boxes and
inHowever,
large C-T l.-'ich
putative "TATA II
no
between either
TATA-like sequence
other yeast genes,
sequences.
It is a characteristic feature of upstream regulatory
elements of many eukaryotic genes that they can act in both
orientations at long distances from the transcriptional
initiation site (Guarente 1984; Serfling et al., 1985). In yeast,
these element.s liave been designated as "upst1.~earn activation
sites" (UASs), whicli resemble, in many l....espects, tIle "enharlcer"
sequences observed in higher eukaryotes. Study of a variety of
yeast genes known to be involved in various pathways of
intermediary metabolism has shown that UAS regions are defined
by DNA sequences which interact with trans-acting factors encoded
by unlinked regulatory genes. A search of the DFRl DNA
sequence obtained in this study for consensus with the core
sequences of yeast UAS elements revealed two repeats of the
sequence tlTG·ACTC II ,(at position -177 and --597 bp upstl."eanl of the
translational initiation codon). This DAB core sequence is
thought to be necessary for the amino acid general control
depression response (Jones and Fink, 1983; Lucchini et al., 1984)
and as the binding target of the transcription factor GCN4 (Arndt
and Fink, 1.986) .. Tl1is finding suggests tl1.at tlle DFRl might also
be regulated by the general amino acid general control system. In
support of this possibility, it is worthy of note that DHFR plays
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a important role in the biosynthesis and metabolism of several
amino acids such as methionine and histidine (Blakley, 1984) and
that the latter amino acid has been shown to be subject to the
amino acid general control in yeast.
In addition to the regulatory elements which can be
identified in the I1NA sequence upstream from tlle DFRl coding
region, several interesting features can also be observed in the
sequence 3' to the gene. It has been suggested that there is a
coupling of yeast RNA transcriptional termination and poly-
adenylation (Zaret and Sherman, 1982). In spite of the fact that
the precise molecular signals for these processes have yet to be
identified, several putative transcriptional termination
sequences have been proposed. For example, the tripartite
consensus sequence (TAG .. ~TAGT/TATGT~... TTT) first observed by
Zared and Sherman (1982) has since been found in many other yeast
genes. In the case of the DFRl gene, three sets of these
matched sequences can be identified, (see Fig.5a; some of these
observations have been obtained by M.G. Nagel, M.Sc. thesis,
Brock University, 1985). In addition, Henikatt et al. (1983) have
observed another sequence ("TTTTTATA U ) thought to be neccessary
for efficient transcription termination in yeast and proposed to
resemble the prokaryotic rho factor-dependent terminators. The
DFRl 3' flanking sequence contains a closely related sequence
(see Fig. 5b). An interesting feature of this region is that it
also shares some features with the prokaryotic rho
factor-indenpent terminators, namely, there are 8 consecutive T
residues 22 bp downstream of the TGA stop codon, preceded by a GC
Figtll~e 5. 3' consensus sequences of the DFRl gene
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(a)
Yeast: TAA/TAG/TGA 1-140 TAG TAGT/TATGT TTT .
DFH1: TGA 31 TATGT 28 TTT .
TGA 40 TAGT 20 TTT .
TGA 40 TAG 3 TAG 51 TAG .. 68 TATGT 16 TTT .
(b)
YEAST: TAA/TAG/TGA .. _ TTTTTATA .
DFR1:
(c)
TGA 24 TTTTTAATA _ .
YEAST: TAA/TAG/TGA _ TAAATAA(G/A) .
DFE1:
( d)
Eukaryote:
DFR1:
(E)
DFR1 :
TGA 36 TAAATAG .
TGA 176 _.. TAAATAATA .
TAA/TAG/TGA AATAAA .
TGP",. . . . . . . . . . . . . . . . . . . . AAATAA. . . . . . . . . . . . . . . . . . . . . . . . . . .
A
A A
GC
T C
AT
A C
AT
T C
GC
CG
T C
A C
A C
CG
AT
TA
AT
TTCACTCTATTTTTTTTAATA
I '
I
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ricll region forrnin.g a portion of a partial dyad symmetl.""y (see
Fig. 5e; Platt, 1981). Also found in the 3' non-coding region of
the DFRl gene are the sequences which very closely resemble the
otl1el.-' consensus sequence "TAAATAA(G/A) tl, proposed by Bennetzen and
Hall (1982) as important for yeast transcriptional termination
and thought to be reminiscent of t11e canol1.ical sequence "AATAAA"
required for pol;)tad,enylation in higher eukar:Y'otes (Fig. 5c) .
Still anotl1el." sequence "AAATAA" located 175 bp downstrea111 from
the termination codon shows considerable homology with the
sequence "AATAAA" postulated to be in1portant for polyadenylation
of eukaryotic mRNAs (Fig.5d, Proudfort and Brownlee, ~976;
Benoist et al., 1980; this observation has also been pointed
out by M.G. Nagel, 1985). Further experiments are necessary to
determine with any certainty that any of these DNA sequences
is responsible for the transcriptional termination and/or
polyadenylation for the DFRl gene in yeast.
D. Codon Usage of the DFRl Gene
In yeast genes, the pattern of codon usage varies
considerably (Bennetzen and Hall, 1982). A survey of the DNA
sequences of the coding region of 110 yeast genes has confirmed a
relationship between the level of expression of a particular gene
and the degree of codon usage bias toward particular triplets,
which is most extreme in highly expressed genes (Sharp, 1986). It
has been demonstrated that genes which are efficiently expressed
utilize preferentially only 25 codons out of the possible 61
coding triplets, whereas genes which are poorly expressed have a
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less restricted pattern of codon usage (Benetzen and Hall, 1982).
These studies have also revealed that for a given amino acid, the
major isoaccepting tRNA species present in yeast possess
anticodons corresponding to the most frequently used triplet,
thus allowing for efficient translation of prefered codons.
Bennetzen and Hall (1982) have defined a codon bias index
(CBI), on a scale of a - 1.0, that quantitates the extent of the
bias towards a set of 22 prefered codons. Thus, when these 22
codons are used exclusively, -the CBI is one, while it is zero
when the usage of these triplets is exactly that expected if the
codons were distributed randomly.
A summary of the codons used in the yeast DFRl mRNA is
presented in Table 4. The CBI of the yeast DHFR mRNA was 0.0083,
calculated according to the rules suggested by Bennetzen and Hall
(1982). This value is very close to zero and indicates almost
totally random codon usage. This suggests that the DFRl gene is
expressed at a relatively low level under normal physiological
conditions.
F. Comparison of Yeast DFRl Amino Acid Sequence with
Other DHFRs
During the last decade, X-ray crystallographic studies and
amino acid sequencing have led to significant advances in our
understanding of the structure of various DHFRs and the molecular
basis of inhibitor and/or cofactor affinities for these proteins.
To date, 12 different DHFR proteins have been completely
sequenced. the predicted amino acid sequences deduced from the
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Table 4" Codon usage of the DFRl gene
AA Cod
no. no ..
cod aa AA Cod
no. no.
cod aa AA Cod
no. no
cod aa
Met AUG
Phe {.lDU
Phe UIle"
lIe ADD"
lIe AUG II
lIe ADA
Leu UVA
Leu DUG"
Leu CUD
Leu CUC
Leu eUA
Leu CUG
3
3
11
18
11
17
11
3
2
2
2
2
:1.
7
4
8
3
11
7
12
5
3
1
6
o
o
5
2
AAU
AAC"
UGc-r
AAA
J.'1.A!] II
CiAU
GAC
GAAII
GAG
UGU"
UGC
CCiU
eGC
eGA
eGG
AGA"
AG'G
GGun
GGe
GGA
GGG
Trp
Asn
Asn
Arg
Al1 g
Arg
Arg
AJ....g
Arg
Asp
Asp
Cys
Cys
Glu
Glu
Gly
Gly
Gly
Gly
9
9
3
6
7
15
1.
3
3
3
4
3
4
3
4
o
3
2
2
1
5
1
2
1
a
o
1
G·CU"
GCCli
GCA
GCG
ceu
eee
CCA"
eCG
ACU"
ACe"
ACA
ACG
Ala
Ala
Ala
Ala
Thr
T11r
Thl-'
Thr
Tyr DAD
Tyr UAC"
Te1~m UAA
Ternl UAG
Term UGA
His CAD
His eAC II
a'ln. CAA tI
GIn CAG
Pro
Pro
Pro
Pl."O
10
18
16
7
12
13
2
2
6
6
7
6
3
7
6
2
1
3
4
o
2
3
I)
~
3
3
1
4
3
GUt]"
GUe ll
GUA,
GUG
DCU"
DeC"
DCA
UCG·
AGU
AGe
Val
V'al
Va,l
Val
Sex'
Ser
Ser
Ser
Ser
Ser
Codons marl{ed by " are those whicli were s110wn by Bennetzell and
Hall (1982) to be selectively used more than 85% of the time in
ADHl and G3PDH genes. Cod = codons, AA or aa = amino acids.
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corresponding DNA sequences of 11 DHFR genes are also available
(see appendix I and II). A comparison of these amino acid
sequences has revealed that, in general, bacterial DHFRs contain
about 160 residues while animal DHFRs have approximately 186
amino acids~ An additional observation is that animal DHFRs show
much greater similarity to each other than do the bacterial
enzymes. In animals, about 125 of a total of 186 amino acids of
the enzyme are identical. Bacterial DHFRs, on the other hand, are
not as homogeneous as animal enzymes, corresponding in only 30 of
the approximate 160 residues present in the entire polypeptide. A
common feature of DHFRs from both prokaryotes and eukaryotes
is a greater homology towards their amino termini. compared to
their carboxy terminal regions. Another common feature of all
DHFR proteins studied to date is a high degree of conservation of
the amino acid residues thought to be involved in the binding of
MTX and NADPH to the enzyme (see Fig.; Volz et al_ ,1982).
In contrast to this wealth of information about a number of
DHFR proteins from a variety of organisms, very little is known
about the yeast enzyme. In fact, so little is known that even the
molecular weight of the yeast DHFR protein is in dispute. Various
values have been reported including 26,000 (Wu et al., 1976;
abstract), 29,000 (C.Geoff, personal communication) and 39,000
Daltons (Blakley, 1984). The 633 bp coding region of the DFRl
gene determined in this study corresponds to a polypeptide of 211
amino acids (Fig. 4 and Fig" 6), with a predicted molecular
weight of 24,229.8 Daltons, in general agreement with the report
of Wu at al. (1976). The yeast DHFR shows greater homology
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towards other DHFR protains in the amino terminal region than in
the carboxy terminal residues (Fig. 6). Based on the alignments
shown in Fig. 6, the yeast DHFR exhibits approximately 25%
sequence homology with the E..coli DHFR, about 20% with both
-the 1.casei and Q. faecium proteins and approximately 30%
similarity with the animal enzymes.
Of 17 residues known to be involved in MTX binding to the
1.casei DHFR (Bolin et al., 1982; Blakley, 1984), 10 are
identical in yeast (namely, Ala13, Leu27, Trp29, Phe38 , Arg39,
Ser63, Phe65, Leu?l, Arg74 and Thr141, see Fig. 6). Of these
residues, 6 are invariant in all DHFRs analyzed (Ala13, Trp29,
Phe38, Leu?l, Arg74 and Thr141). Asp at position 34 is found to
be conserveed in all animal DHFRs but replaced by Glu in all
bacterial DHFRs. The yeast DHFR is similar to other eukaryotes in
this respect ..
Of 27 residues implicated in the binding of NADPH to the
1.casei DHFR (Filman et al., 1982; Blakley, 1984), 13 are
identical in the yeast enzyme (viz. Ala13, 11e21, Gly22, Gly25,
Leu27, Trp29, Gly57, Arg58, Thr60, Ser63, Gly123, Gly124 and
Thr151; see Fig .. 6). 8 of these residues are found to be
invariant in all DHFRs examined to date (i.e. Ala13, Ile21,
Gly22, Trp29, Gly57, Thr60, Gly123 and Gly124). The three others
(Gly22, Leu27 and Ser63) appear to be common to all animal DHFRS
and some bacterial DHFRs whereas the two remaining residues
(Arg58 and Thr60) are conserved in most enzymes, for which
sequencing data is available.
The yeast DHFR is about 25 and 51 residues longer than
Figure 6~ Comparison of the predicted amino acid sequence
witll othel" DHFRs
Sources of other DHFR sequences are indicated in Appendix I
and II. The numbering system is for the yeast protein. The
assignment of the sequences is essentially adapted from Volz
et ale (1982). The one letter code for amino acids is as
follows: A, alanine; C, cysteine; D, aspartate; E,
glutamate; F, phenylanine; G, glycine; H, hisdine; I,
isoleucine; K, lysine; L, leucine; M, methionine; N,
asparagine; P, proline; Q, glutamine; R, arginine; S,
serine; T, threonine; V, valine; W; tryptophan; Y, tyrosine.
Consensus sequences are boxed .
.. : NADPH birldirlg
e: MTX binding
IJC: L .. easei
SF: S.faecium
EC: E.coli
sc: S.cerevisiae
Ch : C11i cken
Bo: Bovine
Hu: Human
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animal and bacterial enzymes, respectively. As shown in Fig. 6,
when the yeast DHFR is compared with animal DHFRs, apart from 4
amino acid residues that lengthen the amino terminus, the 21
additional residues (in excess of the 186 found in other
eukaryotic DHFRs) are located in the region from amino acid 164
to 184. It is noteworthy that this region in animal DHFRs has
been clef ined as a nla.jor insei...tion when conlpal.~ed wi tIl bacte.l~'ial
sequences. This particular insertion is quite different than
others in eukaryotic proteins in that it does not occur in the
loops connecting elements of secondary structure of the
polypeptide (Volz et al. ,1982; Blakley, 1984). The length of this
region in the yeast DHFR is even longer than that of the animal
enzymes. The significance of this insertion is unclear at the
present time, although it has been suggested that it may
contribute t9 the small but critical changes in the relative
positions of elements of secondary structure (Blakley, 1984).
Coincidentally, intron V of the human DHFR gene corresponds
to the 3' end of this insertion present in the yeast DHFR gene.
Thus, conjunction of exons V and VI of the human DHFR· gene is
within the codon GA'A coding for the Glu residue at position 187
in the polypeptide while the 3' end of the insertion of the yeast
DHFR gene ends at the codon GAG' coding for a glutamate at
position 184. These observations prompted a search for any
signals which might be involved in RNA splicing in this region_
The surprising finding is that the sequence "GTATTT"
corresponding to the Val166 and Phe167 residues and sequence
It (G')AG" codirJ.g for the G·lu1.84 residue are located at the 5'
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and 3' end of the insertion, respectively. These sequences
greatly resemble the sequences "GTATGT" and "AG·" which are tIle 5'
and 3' splice junction consensus sequences of introns of at least
15 yeast nuclear genes (Langford and Gallwitz, 1983; Langford et
al., 1984; Teem et al., 1984). In addition to the splice junction
conserved sequences witllin introns, the core sequence fITACTAAC"
has been shown to be absolutely required for processing of
yeast hnRNAs (Pikielnyet a1., 1983; Langford et al., 1984).
Since this sequence is not found in the insertion sequence of
the yeast DFRl gene, Thouggh, / it appears that there are
sequences present in this region wh.ich are necessary but not
sufficient for nuclear intron splicing~
The search for intron consensus homology with the yeast
insertion sequence aslo revealed a partial homology with the
consensus sequences of class II mitocondrial introns (Keller and
Michel, 1985), as shown below:
DFR1:
classII:
5' . . w GAGe w • • U. . . GAAA. . . . . . . . . . . . w • • • • • • • • CUA. . . A . 3 '
5' ... GAG·C ... u... GAAA... A. G· . ... GTT .... G... CUC ... A. 3 '
The significance, if any, of these homologies with intron
consensus sequences of both nuclear and mitochondrial genes
remains unclear.
II. Construction of DFR1:1acZ Gene Fusions
As mentioned previously (see Introduction), lacZ fusions
have been successfully employed in a variety of genetic and
b i c)c}1emical studies ill yeast. lacZ fusions [laVe been
particularly valuable in studies of the regulation of gene
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expression. Thus, it was thought that construction of a
DFR1:1acZ fusion would greatly facilitate the study of the
regulation of DFR1'gene expression in yeast. Previously in our
laboratory, an attempt was made to construct such fusions by an
in vivo selection approach which was based on spontaneous or
induced nonhomologous recombination of the regulatory sequence of
the DFRl with the continuous lacZ gene on the plasmid (D.
Steele, Undergraduate Thesis, Brock Universoty). This study was
hampered by lack of information about the physcial organization
of the cloned DFRl gene. With the availibility of the DNA
sequence data obtained in this study, another approach became
practicable. This method was based on the deletions in vitro
of the 3' terminus of the coding region of the DFRl with
double-stranded DNA exonuclease Ba131, followed by the selection
in vivo of the functional fusion constructions with the
lacZ gene (Guarente, 1983; Rose and Botstein, 1983a). This in
vitro method possesses many advantages. For example, the
deletion end points of the DFRl fragment could be chosen to
lie far from or close to the start codon of the DFRl DNA
fragment to be fused to the lacZ.
In order to construct a hybrid gene between the yeast DFRl
and the E.coli lacZ gene, plasmid pLG669-Z was employed. In
addition to standard features of an E.coli-yeast shuttle
vector, this plasmid had a 'lacZ fragment in which the 5' end
of the lacZ coding sequence including the ATG codon had been
deleted. The 5' end point of this fra.gment was immediately
preceded by a unique BamHl restriction site. Since there was no
75
BamHl restriction site within the coding region of the DFRl
gene, the requisite BamBi site in the coding region was then
introduced by the attachment of synthetic oligonucleotide BamHl
linker onto the ends of Ba131-generated ,DFR1' fragments. To
produce the DFR1:1acZ fusions, another unique restriction
site SaIl, upstream from the BamBi site in the plasmid pLG669-Z,
was used to orientate the insertion of the DFR1' fragments, in
which the appropriate 3' coding sequences had been deleted. Due
to the consideration that the polypepide of the DHFR protein
might have some particular function on the regulation of its own
expression, it was decided to construct two sets of DFR1:1acZ
fusions which retained either almost the entire coding region
of the DFRl gene (pEFZ fusions) or only a small number of the
amino terminal codons of the DFRl gene (pHFZ fusions). It was
thought that these two sets of fusions might have different
regulatory properties.
The pro~edure used in construction of the pEFZ fusions is
shown in Fig.7. By this approach, a total of 11 E. coli
transformants with independent pEFZ fusion plasmids were
obtained. Examination of these transformants on selective M9
medium containing Tm (2ug per ml) indicated that all of them
failed to confer Tm resistance upon the bacterial host,
indicating the loss of the DFRl function. Restriction mapping
of some of these pEFZ fusion plasmids are present in Fig. 8.
Diges·tion with restriction enzyme BamBi and SaIl resulted in the
expected bands of about 1.4 kb (Fig. 8A), which indicated the
correct insertion of the Ba131-generated DFR1' fragment into
Figure 7. Construction of pEFZ fusion plasmids
The expel"'imental procedure was described in "Methods" .
Abbreviations for restriction sites are as folowing: B,
BamBi; E, EcoRl; H, HindIII; P, Pstl; Pv, PvuII; S, SaIl; X,
XhoII.
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Figure 8. Restriction mapping analysis of the fusion
plasmids
Plasmid DNA samples were prepared by the rapid mlnl-
procedure (see Methods). After digested with appropriate
restriction enzymes, DNA fragments were separated by 0.7%
agarose gel electrophoresis. Lambda DNA digested with
restriction enzyme HindIII was used as size marker (23, 9.4,
6.7, 2.3, 2.0, and 0.4 kb).
(A) : pEFZ plasmids were digested with BamBl and SaIl
(B) pEFZ plasmids were digested with HindIII.
lane 1 : pEFZ-2. lane 5: pEFZ-9.
lane 2: pEFZ-3. lane 6: pEFZ-1O.
lane 3: pEFZ-4. lane 7 : pEFZ-l1.
lane 4: pEFZ-8. larle 8: lambda DNA digested with HindIII
(c)
lane 1 :
lane 2:
lane 3:
(D)
lane 1 :
lane 2:
lane 3:
lane 4:
uncut pHFZ-12 plasmid DNA.
pHFZ-12 digested with BamBi and SaIl.
lambda DNA digested with HindIII.
pDSB1-Z digested with BamHl and HindIII.
pDSB1-Z digested with HindIII.
pLG669-Z digested with HindIII.
lambda DNA digested with HindIII.
--:DFRl DNA~
----. pLG669-Z vector DNA.
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the vector pLG669-Z. Digestion with restriction enzyme HindIII
further confirmed this by revealing the existence of the HindIII
restriction site within the coding region of the DFRl gene
(Fig. 8B).
The pHFZ fusion plasmids were constructed according to the
procedure shown in Fig. 9. Several hundred bacterial
transformants with independent pHFZ fusion plasmids were
obtained. 18 independent transformants examined all showed
sensitivity to Tm (2ug/ml). The restriction mapping analysis of
the plasmid pHFZ-12 is shown in Fig. 8e. The plasmid pDSB1-Z was
constructed, for ,use as a control, by an insertion of the intact
cloned Sall/BamHl yeast genomic fragment into the vector
pLG669-Z, so that the intact DFRl gene was laid upstream of the
'lacZ fragment. As shown in Fig. 2, a E. coli host of this
construction was resistant to the growth inhibition of Tm.
III. Expression of DFR1:lacZ Gene Fusions In E. coli And
s. cerevisiae
Expression of hybrid beta-gal activity of fusion products
derived from the DFR1:1acZ constructions was measured
qualititatively on agar solid plate. Functional expression of the
fused genes was evidenced by the appearance pf blue colonies
growing on selection plates containing chromogenic substrate
X-gal. Bacterial transformants with 18 independent pHFZ fusion
plasmids all exhibited blue colour when grown on X-gal-L
selection agar medium after one-day incubation (Fig. liB). In
contrast to these pHFZ fusions, transformants with 11. independent
Figure 9. Construction of pHFZ fusion plasmids
The expel"imental procedure was described in t1Methods" .
Abbreviations for restriction sites are the same as in the
Fig. 7.
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pEFZ fusion plasmids showed no blue colour even after prolonged
incubation for periods up to one week (Fig. l1A). A similar
observation was obtained for transformant with the control
plasmid pDSB1-Z (Fig. llB) Above observations indicated that the
pHFZ fusions directed higher levels of beta-galactosidase than
did the pEFZ fusions in E.coli.
Detection of beta-gal activity in yeast was carried out by
using buffered SD medium (pH 7.0). In contrast to the results
observed in bacteria, -the expression pattern of the pHFZ and pEFZ
fusion plasmids in yeast exhibited obvious two classes. Of the 11
independent pEFZ fusions examined, only 6 directed beta-
galactosidase synthesis (ie. pEFZ-2, pEFZ-4, pEFZ-5, pEFZ-8,
pEFZ-9 and pEFZ-l1; see Fig. 12A). Similarly, among 18 pHFZ
fusions, only 7 expressed beta-galactosidase activity
(namely, pHFZ-2, pHFZ-4, pHFZ-6, pHFZ-8, pHFZ~10, pHFZ-12
and pHFZ-16; see Fig. 12B). Visible blue colour in the yeast
colonies was developed only by increasing the concentration of
X-gal in the buffered selective medium up to 200 ug per ml and
prolonging the incubation for at least 15 days. This observation
indicated that the levels of the beta-galactosidase activity
derived from the pHFZ and pEFZ fusion plasmids in yeast cells
were relatively low. This was confirmed by one other functional
CYC1:1ac fusion carried by plasmid pLG669-Z which exhibited
strong blue colour after even only one day incubation, at the
standard assay condition. However, the control plasmid pDSB1-Z
showed no beta-galactosidase activity.
For more precise measurement of levels of beta-galactosidase
11. on of in E.
Exponential cells (MC1064/pEFZ or pHFZ) from a overnight
culture grown in AMP-LB medium were spotted on same
plate supplemented witll 200 ug per ~ Shown
is the that the been incubated
37°G for
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Figure 12. Expression of the DFR1:lacZ fusions in yeast
Yeast cells containing the plasmids, previously grown in SD
selection medium, were spotted on buffered SD selection
medium supplemented with 200ug X-gal per ml. The results
showed here were the observations' after incubation at 30°C
for 20 days.
A. 1 : pEFZ-l
f). pEFZ-2G·
3: pEFZ-3
4: pEFZ-4
5: pEFZ-5
6: pEFZ-6
7 : pEFZ--7
8: pEFZ-8
9: pEFZ-9
10: pEFZ-l0
'1 1 . pE'FZ-l1.1. _L •
12: [>I>SBl. - Z
13: pLG66£i-Z
B. 1 pH:F'Z -1
f) ~ pEIFZ-2':..A .,..
"). };)tlFZ-3<-) •
4: ~pHF'Z --·4
5: pHFZ-5
6 : pHFZ-6
7: pI-IFZ -7
8: pHFZ-8
9: pFIFZ--9
10: pliFZ-l0
11: pHFZ-l1
12: pf-1FZ-12
13: pHFZ-13
14: pHFZ-14
15: pHFZ-15
16: pHFZ-16
17: pHFZ-17
18: pHFZ-18
19: pLG669·-Z
1 ' 2' 3 4
5' 6' 7' 8
9 10 1 1 1 2
14 1 5 1 6
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activity, quantitive assays were performed by the permeabilized
cell method or the cell lysis method. As shown in Table 5, no
beta-galactosidase activity could be detected in bacterial
transformants with pEFZ fusion plasmids. In contrast to these
construction, pHFZ fusion plasmids all directed relatively much
higher levels of beta-galactosidase activity in E.coli (Table
5). These results were consistent with those observed in the
plate assays. However, if the assay reaction was allowed to last
for up to 24 hs, the extremely low levels of the enzyme activity,
derived from all pEFZ fusions and the pDSBI-Z plasmid as well,
could be detected by this cell lysis method. In yeast, consistent
with the observations in plate assay, 11 of 18 pHFZ fusion
plasmids which expressed beta-galactosidase in E.coli failed
to exhibited the enzyme activity in yeast (pHFZ-l, pHFZ-3,
pHFZ-5, pHFZ-7, pHFZ9, pHFZ-11, pHFZ-13, pHFZ-14, pHFG-15,
pHFG-17 and pHFZ-18; see Table 5), while the 7 others (pHFZ-2,
pHFZ-4, pHFZ-6, pHFZ-8, pHFZ-10, pHFZ-12 and pHFZ-16; see Table
5) expressed relatively higher levels of enzyme activity.
Similarly, among the 11 pEFZ fusions, 6 (pEFZ-2, pEFZ-4, pEFZ-5,
pEFZ-8, pEFZ-9 and pEFZ-l1) expressed higher levels of beta-
gal activity (Table 5), whereas the 5 others had no the enzyme
activity or extremely low activity (pEFZ-l, pEFZ-6, pEFZ-7 and
pEFZ-10; Table 5)~ In general, the levels of enzyme activity
derived from pHFZ fusions were higher than those derived from pEF
fusions. The same expression patterns of these fusion plasmids
were observed by both the cell lysis method and the
permeabilized cell method.
Table 5.
Fusion
plasmid
Expression of DFE1:1acZ fusions
~-Galactosidase activity
E.coli Yeast
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Host (Ml/2B)
pLG669-Z (CYC1:1acZ)
pDSB1-Z (UEEl, lacZ)
pEFZ-l (DFR1:1acZ)
pEFZ-2
pEFZ~-3
PEFZ"-4
pEFZ-5
pEFZ-6
pEFZ-7
pEFZ-8
pEFZ--9
pEFZ-·l0
pEFZ-l1
pHFZ-l (DFR1:1acZ)
pHFZ-2
PHFZ-3
pHFZ-4
pf-IFZ ~ 5
pHFZ-6
pI*lFZ--7
pFIFZ-8
pHFZ-··9
pliFZ-10
pHFZ-~11
pHFZ-12
pHFZ-13
pHFZ-14
pHFZ 15
pHFZ-16
pHFZ-17
pHFZ-18
0 0
5.496
0 a
0.002
0 0.654
0.000
a 0.601
0 0.658
a 0.002
0.005
0 0.67.0
0 0.536
0.002
0 0.492
29 0.000
17 1.708
7 0.000
8 0.784
1.1 0.000
40 1.180
2 0.000
22 1.570
12 0.000
38 1.622
21 0.000
15 1.138
8 0.000
11 0.000
23 0.000
40 1.070
8 0.000
7 0.000
-: not tested. Assay of the enzyme activity in yeast cells
was performed by the permeabilized cell method as described
in Methods. Bacterial assay was the standard (Miller, 1972).
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It is likely that the fusions which expressed higher level
of beta-gal activity in yeast cells represent those in which the
two DNA fragments were joined in frame, thereby resulting in the
functional expression of the hybrid gene in yeast. Such a
conclusion could be easily confirmed by DNA sequence analysis of
the fusion junctions through a simple cloning scheme of these
fragments in M13. This wou1d be greatly aided by availability of
the BamHl restriction site in the junctions and the DNA sequence
of the DFRl gene determined in this study. The isolation of
functional DFR1:LacZ fusions should provide very useful
tools for studies of the expression and regulation of the yeast
DFRl gene.
IV. UV-induced Expression of a DFR1:1acZ Fusion in Yeast
As mentioned previously (see Introduction), intracellular
levels of DHFR activity are responsive to a variety of modulators
such as serum, antifolate and virus. Recently, several studies
have demonstrated that amplification of DHFR gene in mammalian
cells is enhanced by pretreatment with a variety of chemical and
physical carcinogens such as hydroxyurea or UV (Brown et al.,
1983;; Tlsty at al., 1984; Johnston, et al., 1986; Kleinberger et
a1., 1986).
Preliminary studies with a DFR1:1acZ fusion plasmid
(pHFZ-12) in yeast strain Ml/2B demonstrated that the beta-gal
activities derived from the fusion plasmid were inducible by
treatment with UV light (see Fig. 13) As shown,
activity in the UV-treated cells was increased
the enzyme
after the
Figure 13. Kinetics of UV induction of ~-galactosidase in
strain Ml/2B containing a DFR1:1acZ fusion
plasmid~
6: UV treatment
0: no traetment
Yeast Ml/2B cells containing pHFZ-12 were grown in SD medium
supplemented with tryptophan to mid-log phase. 5 ml of this
culture was irradiated in dishes with covers removed at a
fl~ence of about 1 J/m- 2 /s'for 30 seconds. 30 ml of thus
treated culture was incubated at 30 a C. 5 ml samples were
collected at each certain time after the treatment, which
were used for the assay of beta-galactosidase activity by
the permeabilized cell method. Non-treated culture was used
as a control.
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treatment and reached the highest level after subsequent growth
for about 3 h. This induced level of the enzyme activity declined
to the level of that of the non-treated cells after about 6 h
growth. In contrast to these observations, the cells not treated
with UV light showed a stable decrease of the beta-gal activity
during the period that cells were entering stationary phase. The
observation made in the experiments described here suggested
that expression of the DFRl was inducible by UV. It is worthy'
of note tl1.at. the DFR1: lacZ fllsion used in. this stLldy was
carried on a multicopy plasmid. Thus, it is likely that the
induced levels of the enzyme activity are not associated with
gene amplication. It is clear that more detailed experiments are
required to confirm this and to understand the nature of this UV
induction of yeast DHFR expression. However, it is an intriguing
finding and, if supported by further experiments, may indicate an
novel role of DHFR in the cellular response to DNA damage which
has heretofore not been suspected.
v. Construction of a Yeast DFRl Null Allele by Gene
Disruption
In spite of the fact that several laboratories
attempted to isolate a DHFR-deficient strain of ~ .cerevisiae
have
by classical techniques of mutant isolation (J.G. Little,
personal communication), to my knowledge, no such st1""airl is yet
available. The absence of a DHFR-deficient mutant has limited
studies of the yeast DHFR function. As such a mutant strain would
be extremely useful for studies in this regard. It was hoped that
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a yeast DF~l null allele could be constructed in vivo by
gene disruption using the cloned DFRl gene.
The general experimental approach used in gene disruption
studies was that described by Rothstein (1983) and by ShortIe et
al.(1982). The cloned DFRl gene was inactivated in vitro by
insertion of a functional ,URA3 gene within the coding region or
alternately by deletion of both 5' and 3 1 flanking sequences. The
dfrl null allele thus constructed in vitro was then
integrated into the yeast genome by transfection thereby
disrupting the functional DFRl chromosomal locus.
Figure 14 outlines the procedure by which a HindIII/EcoRl
fragmen't which laid entirely within the coding region of the
DFRl was inserted into the integrating vector Yip5. The
resulting plasmid (pDEH-5) carried a functional y'east PRA3 gene
which could be used as a selectable marker in a ura3 host, but
it possessed no DFRl function. Restriction enzyme analysis of
this construction is shown in fig. 16M
Integration, by a single homologous recombination event
between the chromosomal DFRl gene and the internal coding
sequence in the plasmid would result in a direct repeat of the
DFRl gene sequence in which one fragment contained a deletion
in its 5' end and the repeated sequence lacked the 3' region.
Thus, each copy of the DFRl gene in the chromosome would now be
incomplete (see Fig. 14). This procedur~ has the disadvantage
that the resulting strain would have direct repeat sequences
which would give rise to an excision of the plasmid DNA via
homologous recombination at a relatively high frequency, thereby,
Figure 14. Construction of plasmid pDEH-5 and disruption
of DFRl locus
Experimental procedure used in the construction of pDEF-5 is
described in "Methods II. Also shown is the principle of the
disruption of the DFRl locus by using this construction~
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resulting in a restoration of functional DFRl locus and loss of
the selective marker. However, this plasmid construction could be
used to transfect yeast cells in a relatively straightforward
procedure without previous digestion of the DNA with restriction
enzymes.
For other experiments it is more desirable to employ another
procedure by which a more stable dhfr- mutant strain could be
constructed. Fig. 15 shows the procedure used in construction of
plasmid pNBU-3 which carried a DFRl null allele by insertion
of the yeast URA3 gene into its coding region. Characterization
of this DFRl disruption plasmid with restriction enzymes is
present in Fig. 16. In addition, shown in Fig. 17 is the
phenotypic characterization of plasmids pNHO--l and pNBU-3 which
failed to transform an E.coli host to Tm resistance and
plasmid pNBD-2 containing the DFRl allele which canfered Tm
resistance upon the same host. These observations indicated that
the function of the DFRl gene carried by plasmid pNBU-3 had
been disrupted by the URA3 sequence inserted into the internal
HindIII site.
In order to direct the integration of the modified DNA
fragment into the DFRl locus, plasmid pNBU-3 was digested with
restriction enzyme SaIl and BamBi prior to transfection. Thus,
both ends of the DNA fragment had homologous sequences with those
in of chromosomal DFRl locus. A double crossover in both sides
of the URA3 gene would result in an exchange of the non-
functional disrupted dfrl gene for the DNA fragment into the
functional DFRl locus (Fig. 18). Although this construction was
Figure 15. Construction of plasmid pNBU-3
Detailed experilnental procedure was described in "Methods II.
Abbreviations for restriction sites are the same as in
Fig. 7.
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Figure 16M Restriction mapping analysis of plasmids pDEH-5
and pNBU-3
Plasmid DNA samples were preparated by the rapid minu-
procedure (see "Methodsll)~ After digested with appropriate
restriction enzymes, DNA fragments were separated by 0.7%
agarose gel electrophoresis. Lambda DNA digested with
restriction enzyme HindIII was used as size marked.
A. Characterization of plasmid pDEH-5.
lane 1: pDEH-5 not digested.
lane 2: Yip5 digested with BamHi and HindIII.
lane 3: pDEH-5 digested with BamBi and HindIIIM
lane 4: lambda DNA digested with HindIII.
B. Cllaracterization of plasmid pBNlJ-3.
lane 1 : pNBU-3 digested with BamHl.
lane 2: pNBU-3 digested with Hin.dIlI.
lane 3: pNBU-~J digested with Bamlil and HindIII~
lane 4: pNBD-2 digested with BamHl.
lane 5: pNBD-2 digested with HindIII.
lane 6: pNBD-2 digested with BamHl and HindIII.
lane 7: pLG669-Z digested with Hil1dII I .
lane 8: lambda DNA digested with HindIII.
A.
B.
1234
12345678
E H
0.4
'\ ;'
\. ,I
\. /
~.029 O'e
pDEH-5
B H H 8
lz 1 · 3 I 1 · 2 I 0 . 7 .'
'-... /'
" /
pNBU-3
93
Figure 17. Phenotypic characterization of plasmids pNHO-l,
pNBD-2 and pNBU-3.
JF1754/pNHO-l. (no DFR1)
JF1754/pNBD-2. (DFR1)
JF1754/pNBU-3~ (disrupted DFR1)
Exponential cells, previously grown in Amp-LB medium, were
harvested by centrifugation and resuspended in M9 medium
supplemented with Met, His, Leu and Tm (2ug/ml). Aliquots
were taken after appropriate period of incubation at 37 G C
and the growth of the cultures was determined by their OD
values at 600 nm.
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Figure 18 Disruption of DFRl locus ,by plasmid pNBU-3~
95
E
s
--i III " IIIU- [)Jll)
~URA3
I BamH1
l Sal1
H Transfection
s
L-_-~·····~·····~·····~······m··· .
.B
,
s
I
H
f"" •• ""'v ...
B
......-..c ...
S
J
H H B
t.;...·.·.·.·.·.·.·.·kwvuA'l;'lZlZ7l1~·:·:·m:.:.:~.:.:~.:.:.~:.:.:~.: ...~:...~..:..~.....m.:a--...J',..,... .~~.~..
I ,.:- .w
B
I
H
E···················································· )1
S
. .
attemptJed six
transfectants
times in a haploid
were recovered on SD
96
strain Ml/2B, no viable
medium supplemented with
folinic acid, the assumed sole auxotrophic requirement of a yeast
dl1fr- strail1.
This selection scheme was employed because it has been shown
that the use of DHFR-specific inhibitor MTX combined with the
antifolate sulfanilamide (SULF) can efficiently inhibit the
growth of yeast cells, and that such an inhibitory effect could
be overcome by supplementing the growth medium with folinic acid
or the end products of one carbon metabolism (adenine, histidine,
methionine and dTMP; see Fig. 19 and 20). Since wild-type yeast
strains are impermeable to dTMP, a mutant strain permeable to
dTMP is reqtJ.ired for efficient "resclle" of cells growrl in Inedium
containing the antifolates. However, it has been demonstrated
tllat efficient procedures used to isolate tup mutan-ts l1ave a
strong selection for respiratory deficient petites which
simultaneously failed to sporulate. Thus, such mutant strains
were less convenient for the construction of a DHFR disruption.
Due to these considerations, gene disruption experiment was first
carried out in haploid strain Ml/2B by using SD minimal medium
supplied with folinic acid at 250 ug/ml, a standard leve1 for
other yeast folate-deficient mutant strains such as foll,
£012 (Little and Haynse, 1979) and others (Barclay, personal
communication). In six yeast transfection experiments in haploid
strain Ml/2B with plasmid pNBU-3, no matter how much of the DNA
sample was used (from 10 to 70 ug for each transfection), and
plasmid pNBU-3 was digested with only restriction enzyme
Figure 19. Growth rescue of MTX-treated yeast cells by
folinic acid
Cells (Ml/2B) were harvested from an exponential culture
and inoculated at zero time into following media:
_ minimal SD medium.
• minimal SD medium containing sulfanilamide (5mg/ml) and
methotrexate (20ug/ml) .
• : minimal SD medium containing sulfanilamide (5mg/ml),
methotrexate (20ugjml) and folinic acid (250ugjml).
Cell numbers were monitored by a Coulter counter"
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Figure 20~ Growth rescue of MTX-treated yeast cells by Cl
metabolites
Strain TM1/2B permeable to dTMP was used. The cells were
grown in following media:
_ minimal SD medium .
• : minimal SD medium containing SULF (5mg/ml) and MTX
(20ug/ml).
~: minamall SD medium containing SULF (5rng/ml), MTX
(20ug/ml), adenine (30ug/ml), hisdine (20ug/ml),
methionone (20ug/ml) and dTMP (25ug/ml).
The cultures were incubated at 34'C.
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BamHl or both BamBi and SaIl enzymes, or the Sall/BamHl
restriction fragment containing the disrupted DFRl gene by the
URA3 gene was purified or not, no URA3 transfectants were
obtained on the folinic acid-SD selection medium. In contrast,
when the same plasmid was used to transform yeast cells without
previous digestion with restriction enzymes and under the same
selection condition, numerous uracil protrophs were recovered.
These transfectan"ts all carried a functional DFRl gene in
addition to the disrupted dfrl DNA fragment due to a single
crossover between the homologous sequences. These observations
suggested that disruption of the DFRl locus in a haploid
yeast cell might result in the alteration of the host cell
to a phenotype more complex than anticipated, ie.
failed to metabolize 5-CHO-THF or was inviable.
In order to confirm this interpretation, a diploid strain
(TH4) was constructed by a cross of strain LP2729/4B with
another haploid DS1/38. Thus, the diploid contained a homoallelic
ura3 mutation suitable for the gene disruption experiment using
plasmid pNBU-3 or pDEH-5. By using this diploid strain TH4 in two
transfection experiments, URA3+ transfectants presumably
heterozygous for the dfrl disruption loci were easi.ly isolated.
Random spore analysis of diploid transfectants TH4/SBU-12 was
performed on the medium same as used in the haploid transfection
experiments and resulted in Ura-:Ura+ segregants in a ratio of
154:7. This strong bias for uracil auxotrophes i.n the meiotic
products suggested that either the yeast DHFR had an essential
function in yeast cell or alternatively that the Ura+ spore
100
clones harboring the dfr~ allele lacked the enzymatic
activity necessary for the metablism of 5
'
-formyl THF (folinic
acid) _
In order to distinguish between these possibilities, a
mutant strain of DBY747 permeable for dTMP was then isolated
which would facilitate the use of another selective procedure
with the end products of Cl metabolism. Additionally, plasmid
pLBB20 was constructed (Fig. 21), which carried the functional
DFRl gene as well as a yeast LEU2 gene allowing selection of
the plasmid. Thus, a haploid cotransfectant with plasmids pLBB20
and either plasmid pYEH-5 or plasmid pNBU-3 digested with BamBi
and SaIl restriction- enzymes should be viable due to the
protection of the DFRl carried by plasmid pLBB20. Subsequently,
by curing the plasmid pLBB20 and following a selection on various
conditions, it should be possible to characterize the phenotype
of a dfrl null D1Lltant strail1.
Figure 21~ Construction of plasmid pLBB20~
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DISCUSSION AND CONQkQSIONS
The nucleotide sequence of an 1.7 kb yeast genomic
SaIl/BamBi restriction fragment containing the DFRl gene was
determined by the Sanger dideoxynucleotide chain termination
method. Previously, DNA sequences of some segments of this
Sall/BamHl fragment were obtained in our laboratory (Nagel,
1985). Based on the analysis of sequence data from the
EcoRl/BamHl restriction fragment, a translation termination codon
TGA, 27 bp downstream from the EcoRl restriction site was
identified. When this 27 bp region was translated into the
possible amino acid sequences, in all three possible reading
frames, a phenylanine moiety was observed to correspond to a
consensus residue present in the carboxy-terminal region of
several other DHFR proteins. In addition, some canonical
sequences previously determined in other studies as having some
function in transcription termination in yeast were identified
downstream from the putative stop codon. Thus, this investigator
suggested that the 3' terminus of the yeast DFRl gene was
located in this sequence.
The sequence data obtained in this study is in agreement
with this assignment of the 3' terminus of the gene. In this
study, complete sequence of the cloned SaIl/BamBi genomic yeast
DNA was determined which comprised 1784 bp. Within this
restriction fragment, a single open reading frame of 633 bp was
identified. This putative coding region of the yeast DHFR gene is
sufficient to code for a polypeptide of 211 amino acids with a
predicted molecular weight of 24,229.8 Daltons. Comparative
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analysis of the predicted amino acid sequence with various DHFR
proteins indicates that yeast DHFR exhibites significant homology
with both prokaryotic and eukaryotic DHFRs. Many of the consensus
residues are those implicated in the interaction of the prot~in
with cofactor and/or various inhibitors.
In addition to providing details about the physical
properties of the DFRl gene product, -the results of this study
have also provided valuable information about the organization of
the gene and the surrounding DNA sequences in the yeast genome.
As described in tile IIResults II section, potential regulatory
elements were identified in both 5' and 3' flanking regions of
the gene~ Two repeats of the general amino acid control UAS core
sequence uTGACTC" were identified in t11e llpstream region. If
supported by further experimentation, this would suggest a novel
regulatory mode for the DHFR protein in the general amino acid
control system of yeast, and the first inclusion in this family
of genes of an enzyme not directly involved in the intermediary
metabolism of these amino acids. The DFR1:1acZ fusions
constructed during this study will provide convenient molecular
tools for the study in this regard. In addition to this putative
regulatory sequence, analysis of the DNA sequence determined in
this study suggests that the yeast DHFR gene might contain
multiple control regions, reflecting alternate transcription
initiation and termination sites. If supported by further
experimental evidence, this would suggest that the yeast gene is
regulated in a similar manner to DHFR genes of higher eukaryotes.
In addition, homology of the 3' sequences of the DFRl with
various
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proposed consensus sequences as important for RNA
transcriptional termination and polyadenylation suggests "that
this gene would be a good experiment modeL to further investigate
the function of these different consensus sequences in the
regulation of yeast gene expression.
Analysis of codon usage of the yeast DFRl gene was used to
calculate the value of the Codon Bias Index (CBI). A eBl of
0.0083, implies that the gene is expressed at a relatively low
level under normal physiological conditions. This result is in
agreement with biochemical studies in which purification of the
protein proved to be difficult (Wu, et al., 1976), and in which
yields of the purified protein were extremely low. Presumably,
this was due to the fact that the DHFR protein is present in very
low quantities in yeast. Additional support for this view was
obtained here in experiments utilizing the DFR1:1acZ fusions
constructed during the course of this study_ Thus, it was shown
that the fusion peptides encoded on multicopy plasmids were
expressed in yeast transfectants at low levels. Analysis of the
codon usage of several known yeast regulatory genes, which all
possess a CBIvalue very close to zero, has led the suggestion
that, in eukaryotic as in prokaryotic organisms, the use of rare
codons for specific amino acids serves as an attenuation
mechanism in the expression of regulatory genes (Kammerer et al. 1
1984)_ The eEl value of 0.0083 for the DFRl gene combined with
the observation in the gene fusion studies mentioned above may
imply that the yeast DHFR protein has, in addition to its
catalytic activity, some regulatory function.
The sequence information of the DFRl DNA fragment was used
in construction of the two kinds of lacZ gene fusions. Both of
them showed similar expression pattern in yeast, but obviously
different in E.coli. The difference could be accounted for by
the hetergeneous intracellular environment. The low level
expression, in both bacterial and yeast cells, of the functional
DFR1:1acZ fusions was indicated by a comparison with levels
of some other yeast gene fusions with the lacZ, such as the
CYQ1:1acZ fusion carried by the plasmid pLG669-Z. Preliminary
studies with the pHFZ-12 fusion plasmid demonstrated that UV
light induced a transient increase in the expression of the gene.
As pointed out previously, this increased seems to be not
associated with gene amplification. Presently, it is unclear
about the role .of UV-induced expression of the yeast DHFR.
Nevertheless, the finding demonstrated in this study may imply a
noval function of DHFR protain in cellular responses to DNA
damage.
Another novel aspect concerning the yeast DHFR function was
revealed during the course of the gene disruption studies. A
number of experiments were conducted in an attempt to construct a
DFRl gene disruption in a haploid host without success. Based
upon the belief that MTX-treated cells represent a phenocopy of
such a mutant, it was assumed that inclusion of exogenous folinic
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acid in the
requirements
growth medium would
of a strain harboring
satisfy the auxotrophic
a DFRl null allele_ This
seems not to be the case as a diploid transfectant heterozygous
for the gene disruption with the URA3 DNA segregated 2:0 for
the Ura- phenotype, when spore clones were germinated on the
folinic acid mediumM
This result may suggest that yeast cells containing a
non-functional DHFR fail to metabolize 5-formyl-THF. Such a
phenotype has been observed in a DHFR deficient Chinese hamster
cell line (L. Chasin, personal communication)~ Although there is
no obvious involvement of the DHFR protein in either uptake or
metabolism of folinic acid, it is conceivable that DHFR like
other enzymes involved in Cl metabolism might form a component of
a complex with several catalytic activities. Thus, a mutation in
a gene coding for a contiguous protein might affect the function
of a neighboring polypeptide. An alternative explanation is that
DHFR has some essential function in yeast and that lack of this
activity is incompatible with viability. Further characterization
of the DHFR protein and its genetic regulation will be required
to distingush between these posibilities.
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Appendix I. Published amino acid sequences of DHFR
Mouse L1210 lymphoma
MOLlse musculus
Porcine liver
Bt)vine liver
Chicrlen liver
S .. faecil.lm I
s. faecium II
L .. casei
E. coli MB1428
E. coli RT500 I and II
E. coli R67
N .. gono1.... rhoeae
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StC)11.e et al. 1979
Cl1.ang et al. 1978
Smi tIl et al. 1979
Lai et al .. 1979
Kumar et al. 1980
Freisheim et al. 1977
Gleisner et al. 1974
Freisheim 1978
Bennett et al. 1978
Baccanari et al. 1981
Stone and Smith 1979
Baccanari et al. 1984
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Appendix II. Published DNA sequences of DHFR gene
SOUl.""ce
Hun1an
Mouse
Chinese 11.an1s tel."t lung
E. coli K12
E. coli R388
E. coli R483
E. c()li R751
L. casei
L. major
T4 phage
Tn 7
Reference
Chen et ala 1984
Crouse et ala 1982
Melera et ala 1984
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Flensburg and Steen 1986
Andrews et al. 1985
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Purohit and Mathews 1984
Fling and Richards 1983
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